Invesco (IVZ) 10-Q 25 Jul 19 2019 Q2 Quarterly report Financial data

Cover Page

Cover Page	6 Months Ended
	Jun. 30, 2019shares
Cover page.
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2019
Document Transition Report	false
Entity File Number	1-13908
Entity Registrant Name	Invesco Ltd.
Entity Incorporation, State or Country Code	D0
Entity Tax Identification Number	98-0557567
Entity Address, Address Line One	1555 Peachtree Street, N.E.,
Entity Address, Address Line Two	Suite 1800,
Entity Address, City or Town	Atlanta,
Entity Address, State or Province	GA
Entity Address, Postal Zip Code	30309
City Area Code	404
Local Phone Number	892-0896
Title of 12(b) Security	Common stock, $.20 par value
Trading Symbol	IVZ
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	469,793,887
Entity Central Index Key	0000914208
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q2
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Jun. 30, 2019	Dec. 31, 2018
ASSETS
Cash and cash equivalents	$ 1,199.4	$ 1,147.7
Unsettled fund receivables	309.4	191.3
Accounts receivable	664.6	604
Investments	839.9	613.5
Cash and cash equivalents of CIP	235.9	657.7
Accounts receivable and other assets of CIP	186.5	110.8
Investments of CIP	6,659.9	6,213.5
Assets held for policyholders	11,472.6	11,384.8
Prepaid assets	139.2	127.1
Other assets	459.6	126.1
Property, equipment and software, net	567.8	468.7
Intangible assets, net	7,377.3	2,176.1
Goodwill	8,389.3	7,157.1
Total assets	38,501.4	30,978.4
LIABILITIES
Accrued compensation and benefits	726.7	646.5
Accounts payable and accrued expenses	1,950	1,087.2
Debt of CIP	5,149.6	5,226
Other liabilities of CIP	565.7	387.6
Policyholder payables	11,472.6	11,384.8
Unsettled fund payables	281.4	178.7
Long-term debt	2,120.5	2,408.8
Deferred tax liabilities, net	1,538.8	326.4
Total liabilities	23,805.3	21,646
Commitments and contingencies
TEMPORARY EQUITY
Redeemable noncontrolling interests in consolidated entities	396.4	396.2
Equity attributable to Invesco Ltd.:
Preferred shares ($0.20 par value; $1,000 liquidation preference; 4.0 million authorized, issued and outstanding as of June 30, 2019)	4,010.5	0
Common shares ($0.20 par value; 1,050.0 million authorized; 566.1 million and 490.4 million shares issued as of June 30, 2019 and December 31, 2018, respectively)	113.2	98.1
Additional paid-in-capital	7,810.8	6,334.8
Treasury shares	(3,185.2)	(3,003.6)
Retained earnings	5,856.8	5,884.5
Accumulated other comprehensive income/(loss), net of tax	(671.4)	(735)
Total equity attributable to Invesco Ltd.	13,934.7	8,578.8
Equity attributable to nonredeemable noncontrolling interests in consolidated entities	365	357.4
Total permanent equity	14,299.7	8,936.2
Total liabilities, temporary and permanent equity	$ 38,501.4	$ 30,978.4

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Jun. 30, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Preferred stock par value (in usd per share)	$ 0.2
Preferred stock liquidation preference (in usd per share)	$ 1,000
Preferred stock authorized (shares)	4,000,000
Preferred stock issued (shares)	4,000,000	0
Preferred stock outstanding (shares)	4,000,000	0
Common stock par value (in usd per share)	$ 0.2	$ 0.2
Common stock authorized (shares)	1,050,000,000	1,050,000,000
Common stock issued (shares)	566,100,000	490,400,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income (Unaudited) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Operating revenues:
Total operating revenues	$ 1,439.4	$ 1,360.6	$ 2,654	$ 2,716.4
Operating expenses:
Third-party distribution, service and advisory	451.8	408.9	819.8	828
Employee compensation	421.9	379.2	803.2	764.4
Marketing	33.4	32.1	61.4	60.1
Property, office and technology	114.9	98.6	222.1	198.8
General and administrative	94.2	87	178	170.7
Transaction, integration, and restructuring	304.9	23.5	351	42
Total operating expenses	1,421.1	1,029.3	2,435.5	2,064
Operating income	18.3	331.3	218.5	652.4
Other income/(expense):
Equity in earnings of unconsolidated affiliates	12.1	7.3	27.1	17
Interest and dividend income	3.9	2.8	8.6	7
Interest expense	(33)	(29.5)	(66.1)	(52.7)
Other gains and losses, net	24.1	1.4	55.2	(4)
Other income/(expense) of CIP, net	51.1	0.9	90	28.1
Income before income taxes	76.5	314.2	333.3	647.8
Income tax provision	(14.5)	(72.3)	(80.7)	(140.7)
Net income	62	241.9	252.6	507.1
Net (income)/loss attributable to noncontrolling interests in consolidated entities	(21.9)	3.2	(34.8)	(8.1)
Net income attributable to Invesco Ltd.	$ 40.1	$ 245.1	$ 217.8	$ 499
Earnings per common share:
- basic (usd per share)	$ 0.09	$ 0.59	$ 0.52	$ 1.21
- diluted (usd per share)	$ 0.09	$ 0.59	$ 0.52	$ 1.21
Investment management fees
Operating revenues:
Total operating revenues	$ 1,071.3	$ 1,050.5	$ 1,995	$ 2,094.2
Service and distribution fees
Operating revenues:
Total operating revenues	294.1	242.9	513.4	489
Performance fees
Operating revenues:
Total operating revenues	15.7	11.6	37.5	20.7
Other
Operating revenues:
Total operating revenues	$ 58.3	$ 55.6	$ 108.1	$ 112.5

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Statement of Comprehensive Income [Abstract]
Net income	$ 62	$ 241.9	$ 252.6	$ 507.1
Other Comprehensive Income (Loss), net of tax [Abstract]
Currency translation differences on investments in foreign subsidiaries	1.5	(233.6)	62.4	(169)
Other comprehensive income/(loss), net of tax	0.7	1.3	1.2	(0.3)
Other comprehensive income/(loss)	2.2	(232.3)	63.6	(169.3)
Total comprehensive income/(loss)	64.2	9.6	316.2	337.8
Comprehensive loss/(income) attributable to noncontrolling interests in consolidated entities	(21.9)	3.2	(34.8)	(8.1)
Comprehensive income/(loss) attributable to Invesco Ltd.	$ 42.3	$ 12.8	$ 281.4	$ 329.7

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Operating activities:
Net income	$ 252.6	$ 507.1
Adjustments to reconcile net income to net cash provided by/(used in) operating activities:
Amortization and depreciation	76.6	66
Common share-based compensation expense	109.4	81.8
Other (gains)/losses, net	(55.2)	4
Other (gains)/losses of CIP, net	(31.4)	11.1
Equity in earnings of unconsolidated affiliates	(27.1)	(17)
Distributions from equity method investees	2.9	3.4
Changes in operating assets and liabilities, net of business acquisitions:
(Purchase)/sale of investments by CIP, net	(84.5)	9.5
(Purchase)/sale of investments, net	73.2	(37.4)
(Increase)/decrease in receivables	(143.1)	(144.9)
Increase/(decrease) in payables	174	(86.8)
Net cash provided by/(used in) operating activities	347.4	396.8
Investing activities:
Purchase of property, equipment and software	(49)	(46.2)
Purchase of investments by CIP	(2,080.9)	(2,020.5)
Sale of investments by CIP	1,213.5	1,730.7
Purchase of investments	(134.5)	(90.1)
Sale of investments	60.8	75.6
Capital distributions from equity method investees	60.7	2.3
Collateral received/(posted), net	55.2	0
Purchase of business, net of cash acquired	339.9	(1,469.3)
Net cash provided by/(used in) investing activities	(534.3)	(1,817.5)
Financing activities:
Purchases of treasury shares	(143.8)	(46.9)
Dividends paid - common	(245.5)	(244)
Third-party capital invested into CIP	120.7	182.6
Third-party capital distributed by CIP	(48.5)	(62.9)
Borrowings of debt by CIP	834.6	521.5
Repayments of debt by CIP	(396.1)	(427.2)
Net borrowings/(repayments) under credit facility	(289.4)	878.9
Payment of contingent consideration	(8)	(7.1)
Net cash provided by/(used in) financing activities	(176)	794.9
Increase/(decrease) in cash and cash equivalents	(362.9)	(625.8)
Foreign exchange movement on cash and cash equivalents	4.5	(16.7)
Foreign exchange movement on cash and cash equivalents of CIP	(4.1)	(2)
Net cash inflows (outflows) upon consolidation/deconsolidation of CIP	(7.6)	(39.3)
Cash and cash equivalents, beginning of period	1,805.4	2,517.7
Cash and cash equivalents, end of period	1,435.3	1,833.9
Total cash and cash equivalents per consolidated statement of cash flows	$ 1,805.4	$ 2,517.7

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($) $ in Millions	Total	Preferred Shares	Common Shares	Additional Paid-in-Capital	Treasury Shares	Retained Earnings	Accumulated Other Comprehensive Income/(Loss)	Total Equity Attributable to Invesco Ltd.	Nonredeemable Noncontrolling Interests in Consolidated Entities	Redeemable Noncontrolling Interests in Consolidated Entities Temporary Equity
Beginning balance at Dec. 31, 2017	$ 8,955.6		$ 98.1	$ 6,282	$ (2,781.9)	$ 5,489.1	$ (391.2)	$ 8,696.1	$ 259.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	519.1					499		499	20.1
Other comprehensive income/(loss)	(169.3)							(169.3)
Change in noncontrolling interests in consolidated entities, net	39.3								39.3
Dividends - common	(244)					(244)		(244)
Common share-based compensation	81.8			81.8				81.8
Vested common shares	0			(108.4)	108.4			0
Other common share awards	0.6			0.2	0.4			0.6
Purchase of common shares	(46.9)				(46.9)			(46.9)
Ending balance at Jun. 30, 2018	9,136.2		98.1	6,255.6	(2,720)	5,747.3	(563.7)	8,817.3	318.9
Beginning balance at Dec. 31, 2017										$ 243.2
Increase (Decrease) in Temporary Equity [Roll Forward]
Net income										(12)
Change in noncontrolling interests in consolidated entities, net										65.8
Ending balance at Jun. 30, 2018										297
Beginning balance at Mar. 31, 2018	9,190		98.1	6,217.4	(2,715.4)	5,626.6	(331.4)	8,895.3	294.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	257.9					245.1		245.1	12.8
Other comprehensive income/(loss)	(232.3)						(232.3)	(232.3)
Change in noncontrolling interests in consolidated entities, net	11.4								11.4
Dividends - common	(124.4)					(124.4)		(124.4)
Common share-based compensation	40.9			40.9				40.9
Vested common shares				(2.8)	2.8
Other common share awards	0.3			0.1	0.2			0.3
Purchase of common shares	(7.6)				(7.6)			(7.6)
Ending balance at Jun. 30, 2018	9,136.2		98.1	6,255.6	(2,720)	5,747.3	(563.7)	8,817.3	318.9
Beginning balance at Mar. 31, 2018										281
Increase (Decrease) in Temporary Equity [Roll Forward]
Net income										(16)
Change in noncontrolling interests in consolidated entities, net										32
Ending balance at Jun. 30, 2018										297
Beginning balance at Dec. 31, 2018	8,936.2	$ 0	98.1	6,334.8	(3,003.6)	5,884.5	(735)	8,578.8	357.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	228					217.8		217.8	10.2
Other comprehensive income/(loss)	63.6							63.6
Change in noncontrolling interests in consolidated entities, net	(2.6)								(2.6)
Issuance of shares	5,463.8	4,010.5	15.1	1,438.2		0		5,463.8
Dividends - common	(245.5)					(245.5)		(245.5)
Common share-based compensation	109.4			109.4				109.4
Vested common shares	88.7			(71.5)	160.2			88.7
Other common share awards	0.6			(0.1)	0.7			0.6
Purchase of common shares	(342.5)				(342.5)			(342.5)
Ending balance at Jun. 30, 2019	14,299.7	4,010.5	113.2	7,810.8	(3,185.2)	5,856.8	(671.4)	13,934.7	365
Beginning balance at Dec. 31, 2018	396.2									396.2
Increase (Decrease) in Temporary Equity [Roll Forward]
Net income										24.6
Change in noncontrolling interests in consolidated entities, net	0									(24.4)
Ending balance at Jun. 30, 2019	396.4									396.4
Beginning balance at Mar. 31, 2019	9,009.4	0	98.1	6,273.7	(2,971)	5,942.1	(673.6)	8,669.3	340.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	56.4					40.1		40.1	16.3
Other comprehensive income/(loss)	2.2						2.2	2.2
Change in noncontrolling interests in consolidated entities, net	8.6								8.6
Issuance of shares	5,463.8	4,010.5	15.1	1,438.2		0		5,463.8
Dividends - common	(125.4)					(125.4)		(125.4)
Common share-based compensation	59.6			59.6				59.6
Vested common shares	88.7			39.3	49.4			88.7
Other common share awards	0.3				0.3			0.3
Purchase of common shares	(263.9)				(263.9)			(263.9)
Ending balance at Jun. 30, 2019	14,299.7	$ 4,010.5	$ 113.2	$ 7,810.8	$ (3,185.2)	$ 5,856.8	$ (671.4)	$ 13,934.7	$ 365
Beginning balance at Mar. 31, 2019										451.1
Increase (Decrease) in Temporary Equity [Roll Forward]
Net income										5.6
Change in noncontrolling interests in consolidated entities, net										(60.3)
Ending balance at Jun. 30, 2019	$ 396.4									$ 396.4

Accounting Policies

Accounting Policies	6 Months Ended
	Jun. 30, 2019
Accounting Policies [Abstract]
ACCOUNTING POLICIES	ACCOUNTING POLICIES Corporate Information Invesco Ltd. (Parent) and all of its consolidated entities (collectively, the company or Invesco) provide retail and institutional clients with an array of global investment management capabilities. The company operates globally, and its sole business is investment management. Certain disclosures included in the company’s annual report on Form 10-K for the year ended December 31, 2018 (annual report or Form 10-K) are not required to be included on an interim basis in the company’s quarterly reports on Forms 10-Q (Report). The company has condensed or omitted these disclosures. Therefore, this Report should be read in conjunction with the company’s annual report. Basis of Accounting and Consolidation The unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) for interim financial information and with rules and regulations of the Securities and Exchange Commission and consolidate the financial statements of the Parent and all of its controlled subsidiaries. In the opinion of management, the financial statements reflect all adjustments, consisting of normal recurring accruals, which are necessary for the fair statement of the financial condition and results of operations for the periods presented. All significant intercompany transactions, balances, revenues and expenses are eliminated upon consolidation. The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and disclosures in the financial statements. Actual results could differ from those estimates. Accounting Pronouncements Recently Adopted Leases. In February 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update 2016-02, “Leases” (Topic 842). Topic 842 requires that lessees recognize lease assets and lease liabilities on the balance sheet for all leases with a lease term greater than 12 months. The company adopted the leases standard on January 1, 2019 using the modified retrospective approach. The company recorded a right-of-use asset of approximately $200.9 million and lease liability of approximately $251.5 million , primarily related to real estate operating leases on January 1, 2019 with no cumulative-effect adjustment to opening retained earnings. The impact of the adoption of the standard on the Condensed Consolidated Statements of Income for the three and six months ended June 30, 2019 was not material. We continue to recognize lease expenses on a straight-line basis over the lease term. The initial recognition of the right-of-use asset and lease liability represented a non-cash activity related to the statement of cash flows. As of May 24, 2019 , the company recorded an additional right-of-use asset of $144.3 million and lease liability of approximately $144.0 million in connection with the OppenheimerFunds acquisition. These amounts are included in Other assets and Accounts payable and accrued expenses in the table of identified assets acquired and liabilities assumed in Note 2 , “ Business Combinations .” The initial recognition of the right-of-use asset and lease liability represented a non-cash activity related to the statement of cash flows. The package of three practical expedients applicable to the company have been elected which resulted in the company not having to reassess whether expired or existing contracts upon adoption contained a lease as well as retaining the historical classifications of our leases and initial direct costs. The company also elected the hindsight practical expedient in evaluating lessee options. The company elected both at transition and on an ongoing basis, to combine lease and non-lease components in calculating the lease liability and right-of-use asset for all operating leases.

Business Combinations

Business Combinations	6 Months Ended
	Jun. 30, 2019
Business Combinations [Abstract]
BUSINESS COMBINATIONS	BUSINESS COMBINATIONS On May 24, 2019 , the company acquired Massachusetts Mutual Life Insurance Company’s (MassMutual) asset management affiliate, OppenheimerFunds, with consideration to MassMutual and OppenheimerFunds employee shareholders consisting of $19.6 million in cash, 81.9 million shares of common stock and $4.0 billion in perpetual, non-cumulative preferred shares with a 21 -year non-call period and a fixed rate of 5.9% . The 81.9 million shares are composed of 75.7 million common shares issued on the closing date and 6.2 million Invesco restricted common stock awards granted to employee shareholders. MassMutual has an approximate 16.1% stake in the common stock of the combined firm as of June 30, 2019 . Invesco and MassMutual entered into a shareholder agreement, in which MassMutual has customary minority shareholder rights, including representation on Invesco’s board of directors. The shareholder agreement with MassMutual specifies a lock-up period of two years for the common stock and five years for the preferred stock. MassMutual may not sell common or preferred shares received as purchase consideration during the respective lock-up periods. The acquired business enhances the company’s ability to meet client needs through its comprehensive range of high-conviction active, passive and alternative capabilities. The transaction was accounted for under the acquisition method of accounting. Accordingly, the purchase price was allocated to the assets acquired and liabilities assumed based upon their estimated fair values as of the date of the transaction. The issuance of common stock and preferred stock consideration represents a non-cash financing activity related to the statement of cash flows. The following table summarizes the initial estimate of amounts of identified assets acquired and liabilities assumed at the acquisition date, as well as the consideration transferred to acquire OppenheimerFunds. The allocation of the purchase price has been prepared on a preliminary basis and changes to the allocation to certain assets, liabilities and tax estimates may occur as additional information becomes available. The company will finalize the acquisition accounting (including the valuation) within the required measurement period, but in no event not later than one year from May 24, 2019 . Initial $ in millions Fair Value Estimate ASSETS Cash and cash equivalents 360.0 Accounts receivable 133.5 Investments 178.4 Prepaid assets 28.9 Other assets 184.2 Property, equipment and software, net 115.2 Intangible assets (1) 5,205.0 Goodwill (2) 1,180.5 Total assets 7,385.7 LIABILITES Accrued compensation and benefits 262.1 Accounts payable and accrued expenses 344.0 Deferred tax liabilities, net 1,199.1 Total liabilities 1,805.2 Total identifiable net assets 5,580.5 Summary of consideration Cash consideration 19.6 Common stock consideration (3) 1,453.6 Preferred stock consideration (4) 4,010.5 Other consideration (5) 96.8 Total cash and stock consideration 5,580.5 ____________ (1) Intangible assets are comprised of the following: • indefinite-lived intangible asset related to management contracts of $4,955.0 million consists primarily of contracts related to mutual funds. • finite-lived intangible asset related to management contracts of $221.0 million consists primarily of contracts related to sub-advised accounts and has an estimated useful life of eight years . • acquired trade name asset of $29.0 million has an estimated useful life of six years . The intangible assets created in the acquisition are not expected to be deductible for tax purposes. (2) Goodwill is calculated as the difference between the acquisition date fair value of the total consideration transferred and the aggregate values assigned to the assets acquired and liabilities assumed. The goodwill created in the acquisition is not expected to be deductible for tax purposes. The goodwill balance resulted primarily from the opening balance sheet net deferred tax liability. (3) The common shares were fair valued using the company’s market price on closing date and reflects a discount for the common shares issued to MassMutual ( 75,563,041 shares) with a two-year lock-up period, resulting in a value of approximately $19.195 per share. Common shares issued to OppenheimerFunds employee shareholders ( 153,574 shares) were valued at the market price on closing date, which was $20.42 . (4) The preferred shares were fair valued using a discounted cash flow model, resulting in a value of $1,000 per share. (5) Other consideration primarily consists of the fair value of the vested portion of replacement employee common share-based awards. The changes in the carrying amount of goodwill from December 31, 2018 to June 30, 2019 are as follows, with the addition primarily due to the OppenheimerFunds acquisition: $ in millions Net Book Value January 1, 2019 7,157.1 Business combinations 1,171.9 Foreign exchange 60.3 June 30, 2019 8,389.3 Operating revenues of the acquired business from May 24 through June 30, 2019 were approximately $217.1 million , which represents the incremental impact of the acquired business and does not represent the stand-alone results of the acquired business. Net income is not available to be separately reported. Total revenues, expenses and net income of the acquired business in periods subsequent to June 30, 2019 will not be available to be separately reported due to the continued integration of the combined businesses. Transaction and integration costs related to the OppenheimerFunds acquisition included within the Transaction, integration, and restructuring line item on the Condensed Consolidated Statements of Income were $295.7 million and $330.6 million , for the three and six months ended June 30, 2019 . Of these amounts, $49.4 million and $51.9 million during the three and six months ended June 30, 2019 , respectively, were transaction-related costs, which primarily relate to advisory, legal, valuation, and other professional fees. Supplemental Pro Forma Information The following unaudited proforma summary presents consolidated information of the company as if the business combination had occurred on January 1, 2018, the earliest period presented herein. Three months ended June 30, Six months ended June 30, $ in millions 2019 2018 2019 2018 Operating revenues 1,750.9 1,908.6 3,471.7 3,841.6 Net income 89.7 271.6 305.8 575.2 The pro forma adjustments include dividends on preferred shares, transaction costs reflected in the initial periods, and adjustments to depreciation and intangible asset amortization expense. Cost savings or operating synergies expected to result from the acquisition are not included in the pro forma results. These proforma results are not indicative of the actual results of operations that would have been achieved nor are they indicative of future results of operations.

Fair Value Of Assets And Liabil

Fair Value Of Assets And Liabilities	6 Months Ended
	Jun. 30, 2019
Fair Value Disclosures [Abstract]
FAIR VALUE OF ASSETS AND LIABILITIES	FAIR VALUE OF ASSETS AND LIABILITIES The carrying value and fair value of financial instruments are presented in the below summary table. The fair value of financial instruments held by CIP is presented in Note 14 , “ Consolidated Investment Products .” See the company’s most recently filed Form 10-K for additional disclosures on valuation methodology and fair value. June 30, 2019 December 31, 2018 $ in millions Carrying Value Fair Value Carrying Value Fair Value Cash and cash equivalents 1,199.4 1,199.4 1,147.7 1,147.7 Equity investments 474.7 474.7 283.2 283.2 Foreign time deposits (1) 26.8 26.8 28.1 28.1 Assets held for policyholders 11,472.6 11,472.6 11,384.8 11,384.8 Policyholder payables (1) (11,472.6 ) (11,472.6 ) (11,384.8 ) (11,384.8 ) Contingent consideration liability (49.8 ) (49.8 ) (40.9 ) (40.9 ) Long-term debt (1) (2,120.5 ) (2,270.5 ) (2,408.8 ) (2,418.2 ) ____________ (1) These financial instruments are not measured at fair value on a recurring basis. See the most recently filed Form 10-K for additional information about the carrying and fair values of these financial instruments. Foreign time deposits are measured at cost plus accrued interest, which approximates fair value, and are accordingly classified as Level 2 securities. The following table presents, by hierarchy levels, the carrying value of the company’s assets and liabilities, including major security type for equity and debt securities, which are measured at fair value on the company’s Condensed Consolidated Balance Sheets as of June 30, 2019 and December 31, 2018 , respectively: As of June 30, 2019 $ in millions Fair Value Measurements Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs Significant Unobservable Inputs Assets: Cash equivalents: Money market funds 655.4 655.4 — — Investments:* Equity investments: Seed money 230.3 230.3 — — Investments related to deferred compensation plans 240.9 240.9 — — Other equity securities 3.5 3.5 — — Assets held for policyholders 11,472.6 11,472.6 — — Total 12,602.7 12,602.7 — — Liabilities: Contingent consideration liability (49.8 ) — — (49.8 ) Total (49.8 ) — — (49.8 ) As of December 31, 2018 $ in millions Fair Value Measurements Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs Significant Unobservable Inputs Assets: Cash equivalents: Money market funds 367.6 367.6 — — Investments:* Equity investments: Seed money 202.8 202.8 — — Investments related to deferred compensation plans 78.6 78.6 — — Other equity securities 1.8 1.8 — — Assets held for policyholders 11,384.8 11,384.8 — — Total 12,035.6 12,035.6 — — Liabilities: Contingent consideration liability (40.9 ) — — (40.9 ) Total (40.9 ) — — (40.9 ) ____________ * Foreign time deposits of $26.8 million ( December 31, 2018 : 28.1 million ) are excluded from this table. Equity method and other investments of $310.5 million and $27.9 million , respectively, ( December 31, 2018 : $296.3 million and $5.9 million , respectively) are also excluded from this table. These investments are not measured at fair value, in accordance with applicable accounting standards. The following table shows a reconciliation of the beginning and ending fair value measurements for level 3 assets and liabilities during the three and six months ended June 30, 2019 and June 30, 2018 , which are valued using significant unobservable inputs: Three months ended June 30, 2019 Six months ended June 30, 2019 $ in millions Contingent Consideration Liability Contingent Consideration Liability Beginning balance (38.4 ) (40.9 ) Contingent consideration liability acquired in business combination (15.5 ) (15.5 ) Net unrealized gains and losses included in other gains and losses, net* 0.5 (1.0 ) Disposition/settlements 3.6 7.6 Ending balance (49.8 ) (49.8 ) Three months ended June 30, 2018 Six months ended June 30, 2018 $ in millions Contingent Consideration Liability Other Debt Securities Contingent Consideration Liability Other Debt Securities Beginning balance (53.6 ) 6.2 (57.4 ) 9.9 Net unrealized gains and losses included in other gains and losses, net* (0.2 ) — 0.2 — Disposition/settlements 3.7 (6.2 ) 7.1 (9.9 ) Ending balance (50.1 ) — (50.1 ) — _______________ * These unrealized gains and losses are attributable to balances still held at the respective period ends. Put option contracts The company purchased an additional put option contract for $3.9 million in the six months ended June 30, 2019 to hedge economically foreign currency risk on the translation of a portion of its Pound Sterling-denominated earnings into U.S. Dollars, providing coverage through December 31, 2019 . Total Return Swaps In addition to holding equity investments, the company has a total return swap (TRS) to hedge economically certain of these deferred compensation liabilities. The notional value of the total return swap at June 30, 2019 was $136.0 million . During the six months ended June 30, 2019 , market valuation gains of $1.7 million were recognized in other gains and losses, net. The company also has total return swaps with respect to certain ETFs. Under the terms of each total return swap, the company receives the related market gains or losses on the underlying investments and pays a floating rate to the respective counterparty. At June 30, 2019 , the aggregate notional value of the total return swaps was $164.8 million . For the six months ended June 30, 2019 , market valuation gains of $3.3 million were recognized in other gains and losses, net. Contingent Consideration Liability At June 30, 2019 inputs used in the model to determine the liability related to the pre-existing contingent consideration arrangement included assumed growth rates in AUM ranging from (9.44)% to 5.73% (weighted average growth rate of (0.54)% ) and a discount rate of 3.92% . Changes in fair value are recorded in other gains and losses, net in the Condensed Consolidated Statements of Income in the period incurred. An increase in AUM levels and/or a decrease in the discount rate would increase the fair value of the contingent consideration liability, while a decrease in forecasted AUM and/or an increase in the discount rate would decrease the liability. In connection with the OppenheimerFunds acquisition (see Note 2, “Business Combinations”), Invesco acquired a $13.6 million contingent consideration liability related to a historical OppenheimerFunds transaction. The liability is contingent upon the attainment of certain revenue growth objectives during 2019 and 2020. As of June 30, 2019, inputs used to determine the liability related to these arrangements primarily include assumed growth rates in management fees ranging from 28% to 33% and a discount rate of 10.7% .

Investments

Investments	6 Months Ended
	Jun. 30, 2019
Investments [Abstract]
INVESTMENTS	INVESTMENTS The disclosures below include details of the company’s investments. Investments held by CIP are detailed in Note 14 , “ Consolidated Investment Products .” $ in millions June 30, 2019 December 31, 2018 Equity investments: Seed money 230.3 202.8 Investments related to deferred compensation plans 240.9 78.6 Other equity securities 3.5 1.8 Equity method investments 310.5 296.3 Foreign time deposits 26.8 28.1 Other 27.9 5.9 Total investments 839.9 613.5 Available for sale debt investments Realized gains and losses recognized in the Condensed Consolidated Statements of Income during the period from investments classified as available-for-sale are as follows: For the three months ended June 30, 2018 For the six months ended June 30, 2018 $ in millions Proceeds from Sales Gross Realized Gains Gross Realized Losses Proceeds from Sales Gross Realized Gains Gross Realized Losses Collateralized Loan Obligations (CLOs) 9.7 0.8 — 12.3 0.8 — Other debt securities 6.3 — (3.5 ) 6.3 — (3.6 ) 16.0 0.8 (3.5 ) 18.6 0.8 (3.6 ) Equity investments The unrealized gains and losses for the three and six months ended June 30, 2019 , that relate to equity investments still held at June 30, 2019 , were a $12.7 million net gain , and $39.4 million net gain , respectively ( three and six months ended June 30, 2018 : $9.9 million net loss and $9.7 million net loss ).

Long-Term Debt

Long-Term Debt	6 Months Ended
	Jun. 30, 2019
Debt Disclosure [Abstract]
LONG-TERM DEBT	LONG-TERM DEBT The disclosures below include details of the company’s debt. Debt of CIP is detailed in Note 14 , “ Consolidated Investment Products .” June 30, 2019 December 31, 2018 $ in millions Carrying Value (2) Fair Value Carrying Value (2) Fair Value $1.5 billion floating rate credit facility expiring August 11, 2022 41.4 41.4 330.8 330.8 Unsecured Senior Notes (1) : $600 million 3.125% - due November 30, 2022 597.8 614.0 597.5 585.2 $600 million 4.000% - due January 30, 2024 595.4 637.4 594.9 594.5 $500 million 3.750% - due January 15, 2026 495.9 523.8 495.6 487.6 $400 million 5.375% - due November 30, 2043 390.0 453.9 390.0 420.1 Long-term debt 2,120.5 2,270.5 2,408.8 2,418.2 ____________ (1) The company’s senior note indentures contain certain restrictions on mergers or consolidations. Beyond these items, there are no other restrictive covenants in the indentures. (2) The difference between the principal amounts and the carrying values of the senior notes in the table above reflect the unamortized debt issuance costs and discounts. The company maintains approximately $11.3 million in letters of credit from a variety of banks. The letters of credit are generally one -year automatically-renewable facilities and are maintained for various commercial reasons.

Share Capital

Share Capital	6 Months Ended
	Jun. 30, 2019
Equity [Abstract]
SHARE CAPITAL	SHARE CAPITAL The preferred shares issued in connection with the acquisition of OppenheimerFunds have a $0.20 par value, liquidation preference of $1,000 per share and fixed cash dividend rate of 5.90% per annum, payable quarterly on a non-cumulative basis. Shares of preferred stock are not redeemable prior to the 21 st anniversary of their original issue date of May 24, 2019. The number of preferred shares issued and outstanding is represented in the table below: As of In millions June 30, 2019 December 31, 2018 Preferred shares issued (1) 4.0 — Preferred shares outstanding (1) 4.0 — __________ (1) Shares held by MassMutual and are subject to a lock-up period of five years , which disallows the sale of shares by MassMutual during the five-year period beginning on the original issue date of May 24, 2019. The number of common shares and common share equivalents issued are represented in the table below: As of In millions June 30, 2019 December 31, 2018 Common shares issued 566.1 490.4 Less: Treasury shares for which dividend and voting rights do not apply (96.3 ) (93.3 ) Common shares outstanding 469.8 397.1 On May 13, 2019, the company entered into a forward contract to purchase 9.8 million common shares at a strike price of $20.51 per common share. The company recorded treasury shares in the amount of $198.7 million , which was calculated by multiplying the fair market value of Invesco’s common share price as of the hedge completion date of May 30, 2019 by the number of common shares being purchased. The company has recorded a corresponding payable to the counterparty, which represents the present value of the amount to be paid at settlement, discounted by using the implicit interest rate at inception of the forward contract. The implicit interest rate was calculated using the effective interest method. The payable includes a discount on the forward purchase price represented by the difference between the fair market value of the common share price and the strike price on hedge completion date. The forward contract represents a non-cash activity related to the statement of cash flows until the common shares are physically settled, which is expected to occur on January 4, 2021. The company’s total collateral related to forward contracts is approximately $8.6 million , which is recorded in other assets on the Condensed Consolidated Balance Sheet as of June 30, 2019. The company has entered into an additional $200 million forward contract to purchase its common shares, which should be completed in the third quarter of 2019 to be settled on April 1, 2021

Other Comprehensive Income_(Los

Other Comprehensive Income/(Loss)	6 Months Ended
	Jun. 30, 2019
Equity [Abstract]
OTHER COMPREHENSIVE INCOME/(LOSS)	OTHER COMPREHENSIVE INCOME/(LOSS) The components of accumulated other comprehensive income/(loss) were as follows: For the three months ended June 30, 2019 $ in millions Foreign currency translation Employee benefit plans Equity method investments Available-for-sale investments Total Other comprehensive income/(loss) net of tax: Currency translation differences on investments in foreign subsidiaries 1.5 — — — 1.5 Other comprehensive income, net — 0.6 0.1 — 0.7 Other comprehensive income/(loss), net of tax 1.5 0.6 0.1 — 2.2 Beginning balance (556.7 ) (117.5 ) — 0.6 (673.6 ) Other comprehensive income/(loss), net of tax 1.5 0.6 0.1 — 2.2 Ending balance (555.2 ) (116.9 ) 0.1 0.6 (671.4 ) For the six months ended June 30, 2019 $ in millions Foreign currency translation Employee benefit plans Equity method investments Available-for-sale investments Total Other comprehensive income/(loss) net of tax: Currency translation differences on investments in foreign subsidiaries 62.4 — — — 62.4 Other comprehensive income, net — 0.8 0.1 0.3 1.2 Other comprehensive income/(loss), net of tax 62.4 0.8 0.1 0.3 63.6 Beginning balance (617.6 ) (117.7 ) — 0.3 (735.0 ) Other comprehensive income/(loss), net of tax 62.4 0.8 0.1 0.3 63.6 Ending balance (555.2 ) (116.9 ) 0.1 0.6 (671.4 ) For the three months ended June 30, 2018 $ in millions Foreign currency translation Employee benefit plans Equity method investments Available-for-sale investments Total Other comprehensive income/(loss) net of tax: Currency translation differences on investments in foreign subsidiaries (233.6 ) — — — (233.6 ) Other comprehensive income, net — 1.9 — (0.6 ) 1.3 Other comprehensive income/(loss), net of tax (233.6 ) 1.9 — (0.6 ) (232.3 ) Beginning balance (225.9 ) (109.3 ) 2.0 1.8 (331.4 ) Other comprehensive income/(loss), net of tax (233.6 ) 1.9 — (0.6 ) (232.3 ) Ending balance (459.5 ) (107.4 ) 2.0 1.2 (563.7 ) For the six months ended June 30, 2018 $ in millions Foreign currency translation Employee benefit plans Equity method investments Available-for-sale investments Total Other comprehensive income/(loss) net of tax: Currency translation differences on investments in foreign subsidiaries (169.0 ) — — — (169.0 ) Other comprehensive income, net — 2.3 (2.3 ) (0.3 ) (0.3 ) Other comprehensive income/(loss), net of tax (169.0 ) 2.3 (2.3 ) (0.3 ) (169.3 ) Beginning balance (290.5 ) (109.7 ) 4.3 4.7 (391.2 ) Adjustment for adoption of ASU 2016-01 — — — (3.2 ) (3.2 ) January 1, 2018, as adjusted (290.5 ) (109.7 ) 4.3 1.5 (394.4 ) Other comprehensive income/(loss), net of tax (169.0 ) 2.3 (2.3 ) (0.3 ) (169.3 ) Ending balance (459.5 ) (107.4 ) 2.0 1.2 (563.7 ) Net Investment Hedge The company designated certain intercompany debt as a non-derivative net investment hedging instrument against foreign currency exposure related to its net investment in foreign operations. At June 30, 2019 and December 31, 2018 , £130 million ( $165.5 million and $165.6 million , respectively) of intercompany debt was designated as a net investment hedge. For the three and six months ended June 30, 2019 , the Company recognized foreign currency gains of $4.2 million and $0.1 million , respectively ( three and six months ended June 30, 2018 : gains of $10.9 million and $4.3 million , respectively) resulting from the net investment hedge within currency translation differences on investments in foreign subsidiaries in other comprehensive income.

Revenue

Revenue	6 Months Ended
	Jun. 30, 2019
Revenue Recognition and Deferred Revenue [Abstract]
REVENUE	REVENUE The geographic disaggregation of revenue for the three and six months ended June 30, 2019 and 2018 are presented below. There are no revenues attributed to the company’s country of domicile, Bermuda. For the three months ended June 30, $ in millions 2019 2018 Americas 992.3 830.2 EMEA (Europe, Middle East, and Africa) 378.6 456.4 Asia-Pacific 68.5 74.0 Total operating revenues 1,439.4 1,360.6 For the six months ended June 30, $ in millions 2019 2018 Americas 1,752.3 1,648.2 EMEA (Europe, Middle East, and Africa) 758.9 926.3 Asia-Pacific 142.8 141.9 Total operating revenues 2,654.0 2,716.4 The opening and closing balance of deferred carried interest liabilities for the six months ended June 30, 2019 was $61.3 million and $55.9 million , respectively ( December 31, 2018 : $60.4 million and $61.3 million , respectively). During the six months ended June 30, 2019 , $5.9 million ( June 30, 2018 : none ) performance fee revenue was recognized that had been included in the deferred carried interest liability balance at the beginning of the period.

Common Share-Based Compensation

Common Share-Based Compensation	6 Months Ended
	Jun. 30, 2019
Share-based Payment Arrangement [Abstract]
COMMON SHARE-BASED COMPENSATION	COMMON SHARE-BASED COMPENSATION The company recognized total expenses of $109.4 million and $81.8 million related to equity-settled common share-based payment transactions in the six months ended June 30, 2019 and 2018 , respectively. Movements on common share awards during the periods ended June 30 , are detailed below: For the six months ended June 30, 2019 For the six months ended June 30, 2018 Millions of common shares, except fair values Time- Vested Performance- Vested Weighted Average Grant Date Fair Value ($) Time- Vested Performance- Vested Unvested at the beginning of period 12.5 0.9 31.46 12.0 0.9 Granted during the period 15.0 0.6 19.77 5.2 0.4 Forfeited during the period (0.4 ) — 26.63 (0.1 ) — Vested and distributed during the period (6.6 ) (0.1 ) 28.78 (4.6 ) (0.4 ) Unvested at the end of the period 20.5 1.4 24.02 12.5 0.9 As discussed in Note 2 . “ Business Combinations ,” 6.2 million Invesco restricted common stock awards (RSAs) were granted to OppenheimerFunds employee shareholders as part of the consideration transferred for the OppenheimerFunds acquisition. These RSAs generally have a 4 -year cliff-vesting. Dividends and cash payments in lieu of dividends are deferred and are paid at the same rate as on the common shares if and to the extent the award vests. There are accelerated vesting provisions that apply to these RSAs. The total fair value of common shares that vested during the six months ended June 30, 2019 was $133.3 million ( six months ended June 30, 2018 : $153.1 million ). The weighted average grant date fair value of the common share awards that were granted during the six months ended June 30, 2019 was $19.77 ( six months ended June 30, 2018 : $32.52 ). At June 30, 2019 , there was $384.4 million of total unrecognized compensation cost related to non-vested common share awards; that cost is expected to be recognized over a weighted average period of 2.72 years .

Operating Leases

Operating Leases	6 Months Ended
	Jun. 30, 2019
Leases [Abstract]
OPERATING LEASES	OPERATING LEASES The company leases office space in almost all its locations of business, data centers and certain equipment under non-cancelable operating leases. The operating leases have a weighted-average remaining lease term of 6.88 years and generally include one or more options to renew, with renewal terms that can extend the lease term from 2 to 10 years. Certain lease arrangements include an option to terminate the lease if a notification is provided to the landlord within 1 - 2 years prior to the end of the lease term. The company has sole discretion in exercising lease renewal and termination options. The lease terms used in our lease measurements do not include renewal options as they are not reasonably certain to be exercised as of the date of this report. The company elected to combine lease and non-lease components in calculating the lease liability and right-of-use asset for operating leases. Variable lease payments are determined based on the terms and conditions outlined in the lease contracts and are primarily determined in relation to the extent of the company’s usage of the right-of use-asset or the nature and extent of services received from the lessor. As of June 30, 2019 , the right-of-use asset of $334.2 million was included within Other assets, and the lease liability of $379.1 million was included within Accounts payable and accrued expenses, on the Condensed Consolidated Balance Sheet. The components of lease expense for the three and six months ended June 30, 2019 were as follows: $ in millions Three months ended Six months ended June 30, 2019 Operating lease cost 16.1 29.8 Variable lease cost 6.9 12.8 Less: sublease income (0.1 ) (0.3 ) Total lease expense 22.9 42.3 Supplemental cash flow information related to leases for the three and six months ended June 30, 2019 was as follows: $ in millions Three months ended Six months ended June 30, 2019 Operating cash flows from operating leases included in the measurement of lease liabilities 18.5 33.5 Right-of-use assets obtained in exchange for new operating lease liabilities 144.3 148.5 In determining the discount rate, the company considered the interest rate yield for specific interest rate environments and the company’s credit spread at the inception of the lease. The weighted-average discount rate for the operating lease liability for the six months ended June 30, 2019 was 3.53% . As of June 30, 2019 the maturities of the company’s lease liabilities (primarily related to real estate leases) were as follows: $ in millions Year Ending December 31, Lease Liabilities 2019 (excluding the six months ended June 30, 2019) 38.6 2020 71.2 2021 66.6 2022 59.2 2023 52.7 Thereafter 140.2 Total lease payments 428.5 Less: interest (49.4 ) Present value of lease liabilities 379.1 As of December 31, 2018 , the company’s total future commitments by year under non-cancelable operating leases were as follows: $ in millions Total 2019 61.6 2020 56.3 2021 49.3 2022 42.8 2023 36.7 Thereafter 53.5 Gross lease commitments 300.2 Less: future minimum payments expected to be received under non-cancelable subleases (2.5 ) Net lease commitments 297.7

Taxation

Taxation	6 Months Ended
	Jun. 30, 2019
Income Tax Disclosure [Abstract]
TAXATION	TAXATION A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows: $ in millions Gross Unrecognized Income Tax Benefits Balance at December 31, 2018 20.0 Additions for tax positions related to the current year 0.7 Additions for tax positions related to prior years 0.2 Additions for tax positions related to acquisitions 54.1 Other reductions for tax positions related to prior years (5.3 ) Balance at June 30, 2019 69.7 At June 30, 2019 , the total amount of gross unrecognized tax benefits was $69.7 million as compared to the December 31, 2018 total of $20.0 million . As a result of the OppenheimerFunds acquisition, $54.1 million was recorded to the opening balance sheet at May 24, 2019 to reflect OppenheimerFunds’ historical uncertain tax positions. One of OppenheimerFunds’ tax positions was favorably settled during the quarter, resulting in a $5.3 million reduction. Of the total amount of gross unrecognized tax benefits, $53.8 million (net of tax benefits in other jurisdictions and the federal benefit of state taxes) represents the amount of unrecognized tax benefits that, if recognized, would favorably affect the effective tax rate in future periods. The Condensed Consolidated Balance Sheet includes accrued interest and penalties of $12.7 million at June 30, 2019, reflecting $9.5 million for accrued interest and penalties recorded to the opening balance sheet for Oppenheimer’s historical uncertain tax positions. OppenheimerFunds’ pre-closing tax liabilities are subject to indemnification from MassMutual per the transaction agreement. At June 30, 2019 , a tax indemnification asset of $22.1 million is included in “Other assets” as the remainder was funded via the acquired net working capital. As a result of potential legislative changes and settlements with taxing authorities, it is reasonably possible that the company's gross unrecognized tax benefits balance may change within the next twelve months by a range of $5.0 million to $15.0 million .

Earnings Per Common Share

Earnings Per Common Share	6 Months Ended
	Jun. 30, 2019
Earnings Per Share [Abstract]
EARNINGS PER COMMON SHARE	EARNINGS PER COMMON SHARE The calculation of earnings per common share is as follows: For the three months ended June 30, For the six months ended June 30, In millions, except per share data 2019 2018 2019 2018 Net income attributable to Invesco Ltd. 40.1 245.1 217.8 499.0 Invesco Ltd: Weighted average common shares outstanding - basic 431.6 413.9 416.7 412.6 Dilutive effect of non-participating common share-based awards 2.2 0.2 1.5 0.3 Weighted average common shares outstanding - diluted 433.8 414.1 418.2 412.9 Earnings per common share: -basic $0.09 $0.59 $0.52 $1.21 -diluted $0.09 $0.59 $0.52 $1.21 Dividends declared per common share $0.31 $0.30 $0.61 $0.59 See Note 9 , “ Common Share-Based Compensation ,” for a summary of common share awards outstanding under the company’s common share-based compensation programs. These programs could result in the issuance of common shares from time to time that would affect the measurement of basic and diluted earnings per common share. There were 0.8 million common shares of performance-vested awards and no time-vested awards excluded from the computation of diluted earnings per common share during the three and six months ended June 30 , 2019 due to their inclusion being anti-dilutive ( three and six months ended June 30, 2018 : 0.7 million ). There were no contingently issuable common shares excluded from the diluted earnings per common share computation during the three and six months ended June 30, 2019 ( three and six months ended June 30, 2018 : none ), because the necessary performance conditions for the common shares to be issuable had not yet been satisfied at the end of the respective period.

Commitments And Contingencies

Commitments And Contingencies	6 Months Ended
	Jun. 30, 2019
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES Commitments and contingencies may arise in the ordinary course of business. Off Balance Sheet Commitments The company has committed to co-invest in certain sponsored investment products which may be called in future periods. At June 30, 2019 , the company’s undrawn capital commitments were $335.0 million ( December 31, 2018 : $391.6 million ). The Parent and various company subsidiaries have entered into agreements with financial institutions to guarantee certain obligations of other company subsidiaries. The company would be required to perform under these guarantees in the event of certain defaults. The company has not had prior claims or losses pursuant to these contracts and expects the risk of loss to be remote. Legal Contingencies The company is from time to time involved in litigation relating to claims arising in the ordinary course of its business. The nature and progression of litigation can make it difficult to predict the impact a particular lawsuit will have on the company. There are many reasons that the company cannot make these assessments, including, among others, one or more of the following: the proceeding is in its early stages; the damages sought are unspecified, unsupportable, unexplained or uncertain; the claimant is seeking relief other than compensatory damages; the matter presents novel legal claims or other meaningful legal uncertainties; discovery has not started or is not complete; there are significant facts in dispute; and there are other parties who may share in any ultimate liability. In management’s opinion, adequate accrual has been made as of June 30, 2019 to provide for any such losses that may arise from matters for which the company could reasonably estimate an amount. Management is of the opinion that the ultimate resolution of such claims will not materially affect the company’s business, financial position, results of operation or liquidity. Furthermore, in management’s opinion, it is not possible to estimate a range of reasonably possible losses with respect to other litigation contingencies. The investment management industry also is subject to extensive levels of ongoing regulatory oversight and examination. In the United States, United Kingdom, and other jurisdictions in which the company operates, governmental authorities regularly make inquiries, hold investigations and administer market conduct examinations with respect to the company’s compliance with applicable laws and regulations. Additional lawsuits or regulatory enforcement actions arising out of these inquiries may in the future be filed against the company and related entities and individuals in the United States, United Kingdom, and other jurisdictions in which the company and its affiliates operate. Any material loss of investor and/or client confidence as a result of such inquiries and/or litigation could result in a significant decline in AUM, which would have an adverse effect on the company’s future financial results and its ability to grow its business.

Consolidated Investment Product

Consolidated Investment Products (CIP)	6 Months Ended
	Jun. 30, 2019
Consolidated Investment Products [Abstract]
CONSOLIDATED INVESTMENT PRODUCTS (CIP)	CONSOLIDATED INVESTMENT PRODUCTS (CIP) The following table presents the balances related to CIP that are included on the Condensed Consolidated Balance Sheets as well as Invesco’s net interest in the CIP for each period presented. See the company’s most recently filed Form 10-K for additional disclosures on valuation methodology and fair value. As of $ in millions June 30, 2019 December 31, 2018 Cash and cash equivalents of CIP 235.9 657.7 Accounts receivable and other assets of CIP 186.5 110.8 Investments of CIP 6,659.9 6,213.5 Less: Debt of CIP (5,149.6 ) (5,226.0 ) Less: Other liabilities of CIP (565.7 ) (387.6 ) Less: Retained earnings 7.3 7.9 Less: Accumulated other comprehensive income, net of tax (7.2 ) (7.8 ) Less: Equity attributable to redeemable noncontrolling interests (396.4 ) (396.2 ) Less: Equity attributable to nonredeemable noncontrolling interests (364.1 ) (356.5 ) Invesco’s net interests in CIP 606.6 615.8 The following table reflects the impact of consolidation of investment products into the Condensed Consolidated Statements of Income for the three and six months ended June 30 , 2019 and 2018 : Three months ended June 30, Six months ended June 30, $ in millions 2019 2018 2019 2018 Total operating revenues (7.2 ) (7.1 ) (15.9 ) (14.1 ) Total operating expenses 5.4 6.2 8.2 9.4 Operating income (12.6 ) (13.3 ) (24.1 ) (23.5 ) Equity in earnings of unconsolidated affiliates (5.7 ) (2.1 ) 0.9 (6.3 ) Interest and dividend income (1.0 ) — (2.4 ) — Other gains and losses, net (8.3 ) 9.1 (29.0 ) 8.2 Interest and dividend income of CIP 86.7 67.2 171.4 125.0 Interest expense of CIP (54.8 ) (46.4 ) (112.8 ) (85.8 ) Other gains/(losses) of CIP, net 19.2 (19.9 ) 31.4 (11.1 ) Income before income taxes 23.5 (5.4 ) 35.4 6.5 Income tax provision — — — — Net income 23.5 (5.4 ) 35.4 6.5 Net (income)/loss attributable to noncontrolling interests in consolidated entities (21.9 ) 3.2 (34.8 ) (8.1 ) Net income attributable to Invesco Ltd. 1.6 (2.2 ) 0.6 (1.6 ) Non-consolidated VIEs At June 30, 2019 , the company’s carrying value and maximum risk of loss with respect to variable interest entities (VIEs) in which the company is not the primary beneficiary was $173.2 million ( December 31, 2018 : $181.8 million ). Balance Sheet information - newly consolidated VIEs During the six months ended June 30, 2019 , there were two newly consolidated VIEs ( June 30, 2018 : there were two newly consolidated VIEs). The table below illustrates the summary balance sheet amounts related to these products before consolidation into the company. The balances below are reflective of the balances existing at the consolidation date after the initial funding of the investments by the company and unrelated third-party investors. The current period activity for the consolidated funds, including the initial funding and subsequent investment of initial cash balances into underlying investments of CIP, is reflected in the company’s Condensed Consolidated Financial Statements. For the six months ended June 30, 2019 For the six months ended June 30, 2018 $ in millions VIEs VIEs Cash and cash equivalents of CIP 4.0 3.4 Accounts receivable and other assets of CIP 3.0 3.4 Investments of CIP 225.4 584.9 Total assets 232.4 591.7 Debt of CIP 177.9 555.2 Other liabilities of CIP 54.5 36.5 Total liabilities 232.4 591.7 Total equity — — Total liabilities and equity 232.4 591.7 Balance Sheet information - deconsolidated VIEs/VOEs During the six months ended June 30, 2019 , the company determined that it was no longer the primary beneficiary of five VIEs and no longer held the majority voting interest in eight voting rights entities (VOEs) ( June 30, 2018 : the company determined that it was no longer the primary beneficiary of two VIEs). The amounts deconsolidated from the Condensed Consolidated Balance Sheets are illustrated in the table below. There was no net impact to the Condensed Consolidated Statements of Income for the six months ended June 30, 2019 and 2018 from the deconsolidation of these investment products. For the six months ended June 30, 2019 For the six months ended June 30, 2018 $ in millions VIEs VOEs VIEs Cash and cash equivalents of CIP 7.7 (0.1 ) 39.3 Accounts receivable and other assets of CIP 22.1 0.2 8.3 Investments of CIP 613.4 26.7 339.9 Total assets 643.2 26.8 387.5 Debt of CIP 526.2 — 375.3 Other liabilities of CIP 22.2 — 3.2 Total liabilities 548.4 — 378.5 Total equity 94.8 26.8 9.0 Total liabilities and equity 643.2 26.8 387.5 The following tables present the fair value hierarchy levels of certain CIP balances which are measured at fair value as of June 30, 2019 and December 31, 2018 : As of June 30, 2019 $ in millions Fair Value Measurements Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Investments Measured at NAV as a practical expedient Assets: Bank loans 5,554.0 — 5,554.0 — — Bonds 642.2 0.4 641.7 — — Equity securities 246.8 191.3 55.5 — — Equity and fixed income mutual funds 18.9 18.9 — — — Investments in other private equity funds 183.5 — — — 183.5 Real estate investments 14.5 — — 14.5 — Total assets at fair value 6,659.9 210.6 6,251.2 14.5 183.5 As of December 31, 2018 $ in millions Fair Value Measurements Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Investments Measured at NAV as a practical expedient Assets: Bank loans 5,117.0 — 5,117.0 — — Bonds 636.0 — 636.0 — — Equity securities 241.2 208.1 33.1 — — Equity and fixed income mutual funds 18.8 18.8 — — — Investments in other private equity funds 188.7 — — — 188.7 Real estate investments 11.8 — — 11.8 — Total assets at fair value 6,213.5 226.9 5,786.1 11.8 188.7 The following tables show a reconciliation of the beginning and ending fair value measurements for level 3 assets and liabilities using significant unobservable inputs: Three months ended June 30, 2019 Six months ended June 30, 2019 $ in millions Level 3 Assets Level 3 Assets Beginning balance 12.2 11.8 Gains and losses included in the Condensed Consolidated Statements of Income (1) 2.3 2.7 Ending balance 14.5 14.5 Three months ended June 30, 2018 Six months ended June 30, 2018 $ in millions Level 3 Assets Level 3 Assets Beginning balance 81.2 76.2 Purchases 13.0 13.0 Sales (44.8 ) (45.5 ) Gains and losses included in the Condensed Consolidated Statements of Income (1) 2.6 8.3 Ending balance 52.0 52.0 ____________ (1) Included in gains/(losses) of CIP, net in the Condensed Consolidated Statements of Income for the six months ended June 30, 2019 are $2.7 million in net unrealized gains attributable to investments still held at June 30, 2019 by CIP (for the six months ended June 30, 2018 : $21.1 million in net unrealized gains are attributable to investments still held at June 30, 2018 by CIP). The collateral assets held by consolidated CLOs are primarily invested in senior secured bank loans, bonds, and equity securities. Bank loan investments of $5,516.7 million , which comprise the majority of consolidated CLO portfolio collateral, are senior secured corporate loans from a variety of industries, including but not limited to the aerospace and defense, broadcasting, technology, utilities, household products, healthcare, oil and gas, and finance industries. Bank loan investments mature at various dates between 2019 and 2028 , pay interest at LIBOR plus a spread of up to 10.0% , and typically range in S&P credit rating categories from BBB down to unrated. Interest income on bank loans and bonds is recognized based on the unpaid principal balance and stated interest rate of these investments on an accrual basis. At June 30, 2019 , the unpaid principal balance exceeds the fair value of the senior secured bank loans and bonds by approximately $122.4 million ( December 31, 2018 : the unpaid principal balance exceeded the fair value of the senior secured bank loans and bonds by approximately $134.3 million ). Approximately less than 0.18% of the collateral assets were in default as of June 30, 2019 and 2018 . CLO investments are valued based on price quotations provided by third-party pricing sources. These third-party sources aggregate indicative price quotations daily to provide the company with a price for the CLO investments. The company has developed internal controls to review the reasonableness and completeness of these price quotations on a daily basis. If necessary, price quotations are challenged through a third-party pricing challenge process. Notes issued by consolidated CLOs mature at various dates between 2026 and 2032 and have a weighted average maturity of 10.80 years . The notes are issued in various tranches with different risk profiles. The interest rates are generally variable rates based on LIBOR plus a pre-defined spread, which varies from 0.55% for the more senior tranches to 7.45% for the more subordinated tranches. The investors in this debt are not affiliated with the company and have no recourse to the general credit of the company for this debt . Quantitative Information about Level 3 Fair Value Measurements At June 30, 2019 , there were $14.5 million of investments held by consolidated real estate funds that were valued using recent private market transactions. At December 31, 2018, there were $11.8 million of investments held by consolidated real estate funds that were valued using recent private market transactions. The table below summarizes as of June 30, 2019 and December 31, 2018 , the nature of investments that are valued using the NAV as a practical expedient and any related liquidation restrictions or other factors which may impact the ultimate value realized. June 30, 2019 December 31, 2018 in millions, except term data Fair Value Total Unfunded Commitments Weighted Average Remaining Term (2) Fair Value Total Unfunded Commitments Weighted Average Remaining Term (2) Private equity funds (1) $183.5 $100.9 6.6 years $188.7 $101.9 6.1 years ____________ (1) These investments are not subject to redemption; however, for certain funds, the investors may sell or transfer their interest, which may require approval by the general partner of the underlying funds. (2) These investments are expected to be returned through distributions because of liquidations of the funds’ underlying assets over the weighted average periods indicated.

Related Parties

Related Parties	6 Months Ended
	Jun. 30, 2019
Related Party Transactions [Abstract]
RELATED PARTIES	RELATED PARTIES Certain managed funds are deemed to be affiliated entities under the related party definition in ASC 850, “Related Party Disclosures.” Related parties include those defined in the company’s proxy statement. As a result of the OppenheimerFunds acquisition (see Note 2 , “ Business Combinations ”), MassMutual has an approximate 16.1% stake in the common stock of the company and owns all of the outstanding $4.0 billion in perpetual, non-cumulative preferred shares. Based on the level of shares owned by MassMutual and the corresponding customary minority shareholder rights, which includes representation on Invesco’s board of directors, the company considers MassMutual a related party. Affiliated balances are illustrated in the tables below: Three months ended June 30, Six months ended June 30, $ in millions 2019 2018 2019 2018 Affiliated operating revenues: Investment management fees 955.5 925.5 1,771.8 1,841.6 Service and distribution fees 278.6 239.7 488.5 485.0 Performance fees 12.9 2.6 23.4 6.7 Other 54.1 45.9 100.9 100.7 Total affiliated operating revenues 1,301.1 1,213.7 2,384.6 2,434.0 $ in millions June 30, 2019 December 31, 2018 Affiliated asset balances: Cash and cash equivalents 655.4 367.6 Unsettled fund receivables 251.8 105.0 Accounts receivable 300.3 391.4 Investments 595.0 655.7 Assets held for policyholders 11,472.3 11,384.5 Other assets 45.4 3.2 Total affiliated asset balances 13,320.2 12,907.4 Affiliated liability balances: Accrued compensation and benefits 62.4 83.2 Accounts payable and accrued expenses 100.1 64.8 Unsettled fund payables 249.1 100.3 Total affiliated liability balances 411.6 248.3

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2019
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTS On July 25, 2019 , the company announced a second quarter 2019 dividend of $0.31 per share to holders of common shares, payable on September 3, 2019 , to shareholders of record at the close of business on August 15, 2019 with an ex-dividend date of August 14, 2019 . On July 25, 2019 the company announced a preferred dividend of $16.06 per share to the holders of preferred shares, representing the period from May 24, 2019 through August 31, 2019 , payable on September 2, 2019 , to shareholders of record at the close of business on August 16, 2019 .

Accounting Policies (Policy)

Accounting Policies (Policy)	6 Months Ended
	Jun. 30, 2019
Accounting Policies [Abstract]
Basis of Accounting and Consolidation	Basis of Accounting and Consolidation The unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) for interim financial information and with rules and regulations of the Securities and Exchange Commission and consolidate the financial statements of the Parent and all of its controlled subsidiaries. In the opinion of management, the financial statements reflect all adjustments, consisting of normal recurring accruals, which are necessary for the fair statement of the financial condition and results of operations for the periods presented. All significant intercompany transactions, balances, revenues and expenses are eliminated upon consolidation. The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and disclosures in the financial statements. Actual results could differ from those estimates.
Accounting Pronouncements Recently Adopted	Accounting Pronouncements Recently Adopted Leases. In February 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update 2016-02, “Leases” (Topic 842). Topic 842 requires that lessees recognize lease assets and lease liabilities on the balance sheet for all leases with a lease term greater than 12 months. The company adopted the leases standard on January 1, 2019 using the modified retrospective approach. The company recorded a right-of-use asset of approximately $200.9 million and lease liability of approximately $251.5 million , primarily related to real estate operating leases on January 1, 2019 with no cumulative-effect adjustment to opening retained earnings. The impact of the adoption of the standard on the Condensed Consolidated Statements of Income for the three and six months ended June 30, 2019 was not material. We continue to recognize lease expenses on a straight-line basis over the lease term. The initial recognition of the right-of-use asset and lease liability represented a non-cash activity related to the statement of cash flows. As of May 24, 2019 , the company recorded an additional right-of-use asset of $144.3 million and lease liability of approximately $144.0 million in connection with the OppenheimerFunds acquisition. These amounts are included in Other assets and Accounts payable and accrued expenses in the table of identified assets acquired and liabilities assumed in Note 2 , “ Business Combinations .” The initial recognition of the right-of-use asset and lease liability represented a non-cash activity related to the statement of cash flows. The package of three practical expedients applicable to the company have been elected which resulted in the company not having to reassess whether expired or existing contracts upon adoption contained a lease as well as retaining the historical classifications of our leases and initial direct costs. The company also elected the hindsight practical expedient in evaluating lessee options. The company elected both at transition and on an ongoing basis, to combine lease and non-lease components in calculating the lease liability and right-of-use asset for all operating leases.

Business Combinations (Tables)

Business Combinations (Tables)	6 Months Ended
	Jun. 30, 2019
Business Combinations [Abstract]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The following table summarizes the initial estimate of amounts of identified assets acquired and liabilities assumed at the acquisition date, as well as the consideration transferred to acquire OppenheimerFunds. The allocation of the purchase price has been prepared on a preliminary basis and changes to the allocation to certain assets, liabilities and tax estimates may occur as additional information becomes available. The company will finalize the acquisition accounting (including the valuation) within the required measurement period, but in no event not later than one year from May 24, 2019 . Initial $ in millions Fair Value Estimate ASSETS Cash and cash equivalents 360.0 Accounts receivable 133.5 Investments 178.4 Prepaid assets 28.9 Other assets 184.2 Property, equipment and software, net 115.2 Intangible assets (1) 5,205.0 Goodwill (2) 1,180.5 Total assets 7,385.7 LIABILITES Accrued compensation and benefits 262.1 Accounts payable and accrued expenses 344.0 Deferred tax liabilities, net 1,199.1 Total liabilities 1,805.2 Total identifiable net assets 5,580.5 Summary of consideration Cash consideration 19.6 Common stock consideration (3) 1,453.6 Preferred stock consideration (4) 4,010.5 Other consideration (5) 96.8 Total cash and stock consideration 5,580.5 ____________ (1) Intangible assets are comprised of the following: • indefinite-lived intangible asset related to management contracts of $4,955.0 million consists primarily of contracts related to mutual funds. • finite-lived intangible asset related to management contracts of $221.0 million consists primarily of contracts related to sub-advised accounts and has an estimated useful life of eight years . • acquired trade name asset of $29.0 million has an estimated useful life of six years . The intangible assets created in the acquisition are not expected to be deductible for tax purposes. (2) Goodwill is calculated as the difference between the acquisition date fair value of the total consideration transferred and the aggregate values assigned to the assets acquired and liabilities assumed. The goodwill created in the acquisition is not expected to be deductible for tax purposes. The goodwill balance resulted primarily from the opening balance sheet net deferred tax liability. (3) The common shares were fair valued using the company’s market price on closing date and reflects a discount for the common shares issued to MassMutual ( 75,563,041 shares) with a two-year lock-up period, resulting in a value of approximately $19.195 per share. Common shares issued to OppenheimerFunds employee shareholders ( 153,574 shares) were valued at the market price on closing date, which was $20.42 . (4) The preferred shares were fair valued using a discounted cash flow model, resulting in a value of $1,000 per share. (5) Other consideration primarily consists of the fair value of the vested portion of replacement employee common share-based awards.
Schedule of Changes in Carrying Amounts of Goodwill	The changes in the carrying amount of goodwill from December 31, 2018 to June 30, 2019 are as follows, with the addition primarily due to the OppenheimerFunds acquisition: $ in millions Net Book Value January 1, 2019 7,157.1 Business combinations 1,171.9 Foreign exchange 60.3 June 30, 2019 8,389.3
Schedule of Pro Forma Information	The following unaudited proforma summary presents consolidated information of the company as if the business combination had occurred on January 1, 2018, the earliest period presented herein. Three months ended June 30, Six months ended June 30, $ in millions 2019 2018 2019 2018 Operating revenues 1,750.9 1,908.6 3,471.7 3,841.6 Net income 89.7 271.6 305.8 575.2

Fair Value Of Assets And Liab_2

Fair Value Of Assets And Liabilities (Tables)	6 Months Ended
	Jun. 30, 2019
Fair Value Disclosures [Abstract]
Fair Value By Balance Sheet Grouping	The carrying value and fair value of financial instruments are presented in the below summary table. The fair value of financial instruments held by CIP is presented in Note 14 , “ Consolidated Investment Products .” See the company’s most recently filed Form 10-K for additional disclosures on valuation methodology and fair value. June 30, 2019 December 31, 2018 $ in millions Carrying Value Fair Value Carrying Value Fair Value Cash and cash equivalents 1,199.4 1,199.4 1,147.7 1,147.7 Equity investments 474.7 474.7 283.2 283.2 Foreign time deposits (1) 26.8 26.8 28.1 28.1 Assets held for policyholders 11,472.6 11,472.6 11,384.8 11,384.8 Policyholder payables (1) (11,472.6 ) (11,472.6 ) (11,384.8 ) (11,384.8 ) Contingent consideration liability (49.8 ) (49.8 ) (40.9 ) (40.9 ) Long-term debt (1) (2,120.5 ) (2,270.5 ) (2,408.8 ) (2,418.2 ) ____________ (1) These financial instruments are not measured at fair value on a recurring basis. See the most recently filed Form 10-K for additional information about the carrying and fair values of these financial instruments. Foreign time deposits are measured at cost plus accrued interest, which approximates fair value, and are accordingly classified as Level 2 securities.
Tri-Level Hierarchy, Carrying Value	The following table presents, by hierarchy levels, the carrying value of the company’s assets and liabilities, including major security type for equity and debt securities, which are measured at fair value on the company’s Condensed Consolidated Balance Sheets as of June 30, 2019 and December 31, 2018 , respectively: As of June 30, 2019 $ in millions Fair Value Measurements Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs Significant Unobservable Inputs Assets: Cash equivalents: Money market funds 655.4 655.4 — — Investments:* Equity investments: Seed money 230.3 230.3 — — Investments related to deferred compensation plans 240.9 240.9 — — Other equity securities 3.5 3.5 — — Assets held for policyholders 11,472.6 11,472.6 — — Total 12,602.7 12,602.7 — — Liabilities: Contingent consideration liability (49.8 ) — — (49.8 ) Total (49.8 ) — — (49.8 ) As of December 31, 2018 $ in millions Fair Value Measurements Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs Significant Unobservable Inputs Assets: Cash equivalents: Money market funds 367.6 367.6 — — Investments:* Equity investments: Seed money 202.8 202.8 — — Investments related to deferred compensation plans 78.6 78.6 — — Other equity securities 1.8 1.8 — — Assets held for policyholders 11,384.8 11,384.8 — — Total 12,035.6 12,035.6 — — Liabilities: Contingent consideration liability (40.9 ) — — (40.9 ) Total (40.9 ) — — (40.9 ) ____________ * Foreign time deposits of $26.8 million ( December 31, 2018 : 28.1 million ) are excluded from this table. Equity method and other investments of $310.5 million and $27.9 million , respectively, ( December 31, 2018 : $296.3 million and $5.9 million , respectively) are also excluded from this table. These investments are not measured at fair value, in accordance with applicable accounting standards.
Reconciliation of Balance, Fair Value Measurement, Level 3	The following table shows a reconciliation of the beginning and ending fair value measurements for level 3 assets and liabilities during the three and six months ended June 30, 2019 and June 30, 2018 , which are valued using significant unobservable inputs: Three months ended June 30, 2019 Six months ended June 30, 2019 $ in millions Contingent Consideration Liability Contingent Consideration Liability Beginning balance (38.4 ) (40.9 ) Contingent consideration liability acquired in business combination (15.5 ) (15.5 ) Net unrealized gains and losses included in other gains and losses, net* 0.5 (1.0 ) Disposition/settlements 3.6 7.6 Ending balance (49.8 ) (49.8 ) Three months ended June 30, 2018 Six months ended June 30, 2018 $ in millions Contingent Consideration Liability Other Debt Securities Contingent Consideration Liability Other Debt Securities Beginning balance (53.6 ) 6.2 (57.4 ) 9.9 Net unrealized gains and losses included in other gains and losses, net* (0.2 ) — 0.2 — Disposition/settlements 3.7 (6.2 ) 7.1 (9.9 ) Ending balance (50.1 ) — (50.1 ) — _______________ * These unrealized gains and losses are attributable to balances still held at the respective period ends.

Investments (Tables)

Investments (Tables)	6 Months Ended
	Jun. 30, 2019
Investments [Abstract]
Marketable Securities	The disclosures below include details of the company’s investments. Investments held by CIP are detailed in Note 14 , “ Consolidated Investment Products .” $ in millions June 30, 2019 December 31, 2018 Equity investments: Seed money 230.3 202.8 Investments related to deferred compensation plans 240.9 78.6 Other equity securities 3.5 1.8 Equity method investments 310.5 296.3 Foreign time deposits 26.8 28.1 Other 27.9 5.9 Total investments 839.9 613.5
Realized Gains Losses Available-For-Sale Securities	Realized gains and losses recognized in the Condensed Consolidated Statements of Income during the period from investments classified as available-for-sale are as follows: For the three months ended June 30, 2018 For the six months ended June 30, 2018 $ in millions Proceeds from Sales Gross Realized Gains Gross Realized Losses Proceeds from Sales Gross Realized Gains Gross Realized Losses Collateralized Loan Obligations (CLOs) 9.7 0.8 — 12.3 0.8 — Other debt securities 6.3 — (3.5 ) 6.3 — (3.6 ) 16.0 0.8 (3.5 ) 18.6 0.8 (3.6 )

Long-Term Debt (Tables)

Long-Term Debt (Tables)	6 Months Ended
	Jun. 30, 2019
Debt Disclosure [Abstract]
Schedule Of Long-Term Debt Instruments	The disclosures below include details of the company’s debt. Debt of CIP is detailed in Note 14 , “ Consolidated Investment Products .” June 30, 2019 December 31, 2018 $ in millions Carrying Value (2) Fair Value Carrying Value (2) Fair Value $1.5 billion floating rate credit facility expiring August 11, 2022 41.4 41.4 330.8 330.8 Unsecured Senior Notes (1) : $600 million 3.125% - due November 30, 2022 597.8 614.0 597.5 585.2 $600 million 4.000% - due January 30, 2024 595.4 637.4 594.9 594.5 $500 million 3.750% - due January 15, 2026 495.9 523.8 495.6 487.6 $400 million 5.375% - due November 30, 2043 390.0 453.9 390.0 420.1 Long-term debt 2,120.5 2,270.5 2,408.8 2,418.2 ____________ (1) The company’s senior note indentures contain certain restrictions on mergers or consolidations. Beyond these items, there are no other restrictive covenants in the indentures. (2) The difference between the principal amounts and the carrying values of the senior notes in the table above reflect the unamortized debt issuance costs and discounts.

Share Capital (Tables)

Share Capital (Tables)	6 Months Ended
	Jun. 30, 2019
Equity [Abstract]
Movements In Shares Issued And Outstanding	The number of preferred shares issued and outstanding is represented in the table below: As of In millions June 30, 2019 December 31, 2018 Preferred shares issued (1) 4.0 — Preferred shares outstanding (1) 4.0 — __________ (1) Shares held by MassMutual and are subject to a lock-up period of five years , which disallows the sale of shares by MassMutual during the five-year period beginning on the original issue date of May 24, 2019. The number of common shares and common share equivalents issued are represented in the table below: As of In millions June 30, 2019 December 31, 2018 Common shares issued 566.1 490.4 Less: Treasury shares for which dividend and voting rights do not apply (96.3 ) (93.3 ) Common shares outstanding 469.8 397.1

Other Comprehensive Income_(L_2

Other Comprehensive Income/(Loss) (Tables)	6 Months Ended
	Jun. 30, 2019
Equity [Abstract]
Accumulated Other Comprehensive Income	The components of accumulated other comprehensive income/(loss) were as follows: For the three months ended June 30, 2019 $ in millions Foreign currency translation Employee benefit plans Equity method investments Available-for-sale investments Total Other comprehensive income/(loss) net of tax: Currency translation differences on investments in foreign subsidiaries 1.5 — — — 1.5 Other comprehensive income, net — 0.6 0.1 — 0.7 Other comprehensive income/(loss), net of tax 1.5 0.6 0.1 — 2.2 Beginning balance (556.7 ) (117.5 ) — 0.6 (673.6 ) Other comprehensive income/(loss), net of tax 1.5 0.6 0.1 — 2.2 Ending balance (555.2 ) (116.9 ) 0.1 0.6 (671.4 ) For the six months ended June 30, 2019 $ in millions Foreign currency translation Employee benefit plans Equity method investments Available-for-sale investments Total Other comprehensive income/(loss) net of tax: Currency translation differences on investments in foreign subsidiaries 62.4 — — — 62.4 Other comprehensive income, net — 0.8 0.1 0.3 1.2 Other comprehensive income/(loss), net of tax 62.4 0.8 0.1 0.3 63.6 Beginning balance (617.6 ) (117.7 ) — 0.3 (735.0 ) Other comprehensive income/(loss), net of tax 62.4 0.8 0.1 0.3 63.6 Ending balance (555.2 ) (116.9 ) 0.1 0.6 (671.4 ) For the three months ended June 30, 2018 $ in millions Foreign currency translation Employee benefit plans Equity method investments Available-for-sale investments Total Other comprehensive income/(loss) net of tax: Currency translation differences on investments in foreign subsidiaries (233.6 ) — — — (233.6 ) Other comprehensive income, net — 1.9 — (0.6 ) 1.3 Other comprehensive income/(loss), net of tax (233.6 ) 1.9 — (0.6 ) (232.3 ) Beginning balance (225.9 ) (109.3 ) 2.0 1.8 (331.4 ) Other comprehensive income/(loss), net of tax (233.6 ) 1.9 — (0.6 ) (232.3 ) Ending balance (459.5 ) (107.4 ) 2.0 1.2 (563.7 ) For the six months ended June 30, 2018 $ in millions Foreign currency translation Employee benefit plans Equity method investments Available-for-sale investments Total Other comprehensive income/(loss) net of tax: Currency translation differences on investments in foreign subsidiaries (169.0 ) — — — (169.0 ) Other comprehensive income, net — 2.3 (2.3 ) (0.3 ) (0.3 ) Other comprehensive income/(loss), net of tax (169.0 ) 2.3 (2.3 ) (0.3 ) (169.3 ) Beginning balance (290.5 ) (109.7 ) 4.3 4.7 (391.2 ) Adjustment for adoption of ASU 2016-01 — — — (3.2 ) (3.2 ) January 1, 2018, as adjusted (290.5 ) (109.7 ) 4.3 1.5 (394.4 ) Other comprehensive income/(loss), net of tax (169.0 ) 2.3 (2.3 ) (0.3 ) (169.3 ) Ending balance (459.5 ) (107.4 ) 2.0 1.2 (563.7 )

Revenue (Tables)

Revenue (Tables)	6 Months Ended
	Jun. 30, 2019
Revenue Recognition and Deferred Revenue [Abstract]
Geographic disaggregation of revenue	The geographic disaggregation of revenue for the three and six months ended June 30, 2019 and 2018 are presented below. There are no revenues attributed to the company’s country of domicile, Bermuda. For the three months ended June 30, $ in millions 2019 2018 Americas 992.3 830.2 EMEA (Europe, Middle East, and Africa) 378.6 456.4 Asia-Pacific 68.5 74.0 Total operating revenues 1,439.4 1,360.6 For the six months ended June 30, $ in millions 2019 2018 Americas 1,752.3 1,648.2 EMEA (Europe, Middle East, and Africa) 758.9 926.3 Asia-Pacific 142.8 141.9 Total operating revenues 2,654.0 2,716.4

Common Share-Based Compensati_2

Common Share-Based Compensation (Tables)	6 Months Ended
	Jun. 30, 2019
Share-based Payment Arrangement [Abstract]
Movements Of Share Awards	Movements on common share awards during the periods ended June 30 , are detailed below: For the six months ended June 30, 2019 For the six months ended June 30, 2018 Millions of common shares, except fair values Time- Vested Performance- Vested Weighted Average Grant Date Fair Value ($) Time- Vested Performance- Vested Unvested at the beginning of period 12.5 0.9 31.46 12.0 0.9 Granted during the period 15.0 0.6 19.77 5.2 0.4 Forfeited during the period (0.4 ) — 26.63 (0.1 ) — Vested and distributed during the period (6.6 ) (0.1 ) 28.78 (4.6 ) (0.4 ) Unvested at the end of the period 20.5 1.4 24.02 12.5 0.9

Operating Leases (Tables)

Operating Leases (Tables)	6 Months Ended
	Jun. 30, 2019
Leases [Abstract]
Components of Lease Expense and Supplemental Cash Flow Information Related to Leases	The components of lease expense for the three and six months ended June 30, 2019 were as follows: $ in millions Three months ended Six months ended June 30, 2019 Operating lease cost 16.1 29.8 Variable lease cost 6.9 12.8 Less: sublease income (0.1 ) (0.3 ) Total lease expense 22.9 42.3 Supplemental cash flow information related to leases for the three and six months ended June 30, 2019 was as follows: $ in millions Three months ended Six months ended June 30, 2019 Operating cash flows from operating leases included in the measurement of lease liabilities 18.5 33.5 Right-of-use assets obtained in exchange for new operating lease liabilities 144.3 148.5
Maturities of Company's Lease Liabilities	As of June 30, 2019 the maturities of the company’s lease liabilities (primarily related to real estate leases) were as follows: $ in millions Year Ending December 31, Lease Liabilities 2019 (excluding the six months ended June 30, 2019) 38.6 2020 71.2 2021 66.6 2022 59.2 2023 52.7 Thereafter 140.2 Total lease payments 428.5 Less: interest (49.4 ) Present value of lease liabilities 379.1
Schedule of Future Commitments Under Non-cancelable Operating Leases	As of December 31, 2018 , the company’s total future commitments by year under non-cancelable operating leases were as follows: $ in millions Total 2019 61.6 2020 56.3 2021 49.3 2022 42.8 2023 36.7 Thereafter 53.5 Gross lease commitments 300.2 Less: future minimum payments expected to be received under non-cancelable subleases (2.5 ) Net lease commitments 297.7

Taxation (Tables)

Taxation (Tables)	6 Months Ended
	Jun. 30, 2019
Income Tax Disclosure [Abstract]
Reconciliation of beginning and ending amounts of unrecognized tax benefits	A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows: $ in millions Gross Unrecognized Income Tax Benefits Balance at December 31, 2018 20.0 Additions for tax positions related to the current year 0.7 Additions for tax positions related to prior years 0.2 Additions for tax positions related to acquisitions 54.1 Other reductions for tax positions related to prior years (5.3 ) Balance at June 30, 2019 69.7

Earnings Per Common Share (Tabl

Earnings Per Common Share (Tables)	6 Months Ended
	Jun. 30, 2019
Earnings Per Share [Abstract]
Calculation Of Earnings Per Share	The calculation of earnings per common share is as follows: For the three months ended June 30, For the six months ended June 30, In millions, except per share data 2019 2018 2019 2018 Net income attributable to Invesco Ltd. 40.1 245.1 217.8 499.0 Invesco Ltd: Weighted average common shares outstanding - basic 431.6 413.9 416.7 412.6 Dilutive effect of non-participating common share-based awards 2.2 0.2 1.5 0.3 Weighted average common shares outstanding - diluted 433.8 414.1 418.2 412.9 Earnings per common share: -basic $0.09 $0.59 $0.52 $1.21 -diluted $0.09 $0.59 $0.52 $1.21 Dividends declared per common share $0.31 $0.30 $0.61 $0.59

Consolidated Investment Produ_2

Consolidated Investment Products (CIP) (Tables)	6 Months Ended
	Jun. 30, 2019
Consolidated Investment Products [Abstract]
Balances Related To CIP	The following table presents the balances related to CIP that are included on the Condensed Consolidated Balance Sheets as well as Invesco’s net interest in the CIP for each period presented. See the company’s most recently filed Form 10-K for additional disclosures on valuation methodology and fair value. As of $ in millions June 30, 2019 December 31, 2018 Cash and cash equivalents of CIP 235.9 657.7 Accounts receivable and other assets of CIP 186.5 110.8 Investments of CIP 6,659.9 6,213.5 Less: Debt of CIP (5,149.6 ) (5,226.0 ) Less: Other liabilities of CIP (565.7 ) (387.6 ) Less: Retained earnings 7.3 7.9 Less: Accumulated other comprehensive income, net of tax (7.2 ) (7.8 ) Less: Equity attributable to redeemable noncontrolling interests (396.4 ) (396.2 ) Less: Equity attributable to nonredeemable noncontrolling interests (364.1 ) (356.5 ) Invesco’s net interests in CIP 606.6 615.8
Condensed Consolidating Statement Of Income Line Items Reflecting Impact Of Consolidation Of Investment Products Into The Condensed Consolidated Statements Of Income	The following table reflects the impact of consolidation of investment products into the Condensed Consolidated Statements of Income for the three and six months ended June 30 , 2019 and 2018 : Three months ended June 30, Six months ended June 30, $ in millions 2019 2018 2019 2018 Total operating revenues (7.2 ) (7.1 ) (15.9 ) (14.1 ) Total operating expenses 5.4 6.2 8.2 9.4 Operating income (12.6 ) (13.3 ) (24.1 ) (23.5 ) Equity in earnings of unconsolidated affiliates (5.7 ) (2.1 ) 0.9 (6.3 ) Interest and dividend income (1.0 ) — (2.4 ) — Other gains and losses, net (8.3 ) 9.1 (29.0 ) 8.2 Interest and dividend income of CIP 86.7 67.2 171.4 125.0 Interest expense of CIP (54.8 ) (46.4 ) (112.8 ) (85.8 ) Other gains/(losses) of CIP, net 19.2 (19.9 ) 31.4 (11.1 ) Income before income taxes 23.5 (5.4 ) 35.4 6.5 Income tax provision — — — — Net income 23.5 (5.4 ) 35.4 6.5 Net (income)/loss attributable to noncontrolling interests in consolidated entities (21.9 ) 3.2 (34.8 ) (8.1 ) Net income attributable to Invesco Ltd. 1.6 (2.2 ) 0.6 (1.6 )
VIE Balance Sheets Consolidated In Period	The amounts deconsolidated from the Condensed Consolidated Balance Sheets are illustrated in the table below. There was no net impact to the Condensed Consolidated Statements of Income for the six months ended June 30, 2019 and 2018 from the deconsolidation of these investment products. For the six months ended June 30, 2019 For the six months ended June 30, 2018 $ in millions VIEs VOEs VIEs Cash and cash equivalents of CIP 7.7 (0.1 ) 39.3 Accounts receivable and other assets of CIP 22.1 0.2 8.3 Investments of CIP 613.4 26.7 339.9 Total assets 643.2 26.8 387.5 Debt of CIP 526.2 — 375.3 Other liabilities of CIP 22.2 — 3.2 Total liabilities 548.4 — 378.5 Total equity 94.8 26.8 9.0 Total liabilities and equity 643.2 26.8 387.5 For the six months ended June 30, 2019 For the six months ended June 30, 2018 $ in millions VIEs VIEs Cash and cash equivalents of CIP 4.0 3.4 Accounts receivable and other assets of CIP 3.0 3.4 Investments of CIP 225.4 584.9 Total assets 232.4 591.7 Debt of CIP 177.9 555.2 Other liabilities of CIP 54.5 36.5 Total liabilities 232.4 591.7 Total equity — — Total liabilities and equity 232.4 591.7
Fair Value Hierarchy Levels Of Investments Held And Notes Issued By Consolidated Investment Products	The following tables present the fair value hierarchy levels of certain CIP balances which are measured at fair value as of June 30, 2019 and December 31, 2018 : As of June 30, 2019 $ in millions Fair Value Measurements Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Investments Measured at NAV as a practical expedient Assets: Bank loans 5,554.0 — 5,554.0 — — Bonds 642.2 0.4 641.7 — — Equity securities 246.8 191.3 55.5 — — Equity and fixed income mutual funds 18.9 18.9 — — — Investments in other private equity funds 183.5 — — — 183.5 Real estate investments 14.5 — — 14.5 — Total assets at fair value 6,659.9 210.6 6,251.2 14.5 183.5 As of December 31, 2018 $ in millions Fair Value Measurements Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Investments Measured at NAV as a practical expedient Assets: Bank loans 5,117.0 — 5,117.0 — — Bonds 636.0 — 636.0 — — Equity securities 241.2 208.1 33.1 — — Equity and fixed income mutual funds 18.8 18.8 — — — Investments in other private equity funds 188.7 — — — 188.7 Real estate investments 11.8 — — 11.8 — Total assets at fair value 6,213.5 226.9 5,786.1 11.8 188.7
Beginning And Ending Fair Value Measurements For Level 3 Assets And Liabilities	The following tables show a reconciliation of the beginning and ending fair value measurements for level 3 assets and liabilities using significant unobservable inputs: Three months ended June 30, 2019 Six months ended June 30, 2019 $ in millions Level 3 Assets Level 3 Assets Beginning balance 12.2 11.8 Gains and losses included in the Condensed Consolidated Statements of Income (1) 2.3 2.7 Ending balance 14.5 14.5 Three months ended June 30, 2018 Six months ended June 30, 2018 $ in millions Level 3 Assets Level 3 Assets Beginning balance 81.2 76.2 Purchases 13.0 13.0 Sales (44.8 ) (45.5 ) Gains and losses included in the Condensed Consolidated Statements of Income (1) 2.6 8.3 Ending balance 52.0 52.0 ____________ (1) Included in gains/(losses) of CIP, net in the Condensed Consolidated Statements of Income for the six months ended June 30, 2019 are $2.7 million in net unrealized gains attributable to investments still held at June 30, 2019 by CIP (for the six months ended June 30, 2018 : $21.1 million in net unrealized gains are attributable to investments still held at June 30, 2018 by CIP).
Fair Value Inputs, Assets and Liabilities, Quantitative Information, Consolidated Investment Products	The table below summarizes as of June 30, 2019 and December 31, 2018 , the nature of investments that are valued using the NAV as a practical expedient and any related liquidation restrictions or other factors which may impact the ultimate value realized. June 30, 2019 December 31, 2018 in millions, except term data Fair Value Total Unfunded Commitments Weighted Average Remaining Term (2) Fair Value Total Unfunded Commitments Weighted Average Remaining Term (2) Private equity funds (1) $183.5 $100.9 6.6 years $188.7 $101.9 6.1 years ____________ (1) These investments are not subject to redemption; however, for certain funds, the investors may sell or transfer their interest, which may require approval by the general partner of the underlying funds. (2) These investments are expected to be returned through distributions because of liquidations of the funds’ underlying assets over the weighted average periods indicated.

Related Parties (Tables)

Related Parties (Tables)	6 Months Ended
	Jun. 30, 2019
Related Party Transactions [Abstract]
Schedule of Related Party Transactions	ffiliated balances are illustrated in the tables below: Three months ended June 30, Six months ended June 30, $ in millions 2019 2018 2019 2018 Affiliated operating revenues: Investment management fees 955.5 925.5 1,771.8 1,841.6 Service and distribution fees 278.6 239.7 488.5 485.0 Performance fees 12.9 2.6 23.4 6.7 Other 54.1 45.9 100.9 100.7 Total affiliated operating revenues 1,301.1 1,213.7 2,384.6 2,434.0 $ in millions June 30, 2019 December 31, 2018 Affiliated asset balances: Cash and cash equivalents 655.4 367.6 Unsettled fund receivables 251.8 105.0 Accounts receivable 300.3 391.4 Investments 595.0 655.7 Assets held for policyholders 11,472.3 11,384.5 Other assets 45.4 3.2 Total affiliated asset balances 13,320.2 12,907.4 Affiliated liability balances: Accrued compensation and benefits 62.4 83.2 Accounts payable and accrued expenses 100.1 64.8 Unsettled fund payables 249.1 100.3 Total affiliated liability balances 411.6 248.3

Accounting Policies (Details)

Accounting Policies (Details) - USD ($) $ in Millions	Jun. 30, 2019	May 24, 2019	Jan. 01, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Right-of-use asset	$ 334.2
Lease liability	$ 379.1
OppenheimerFunds
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Right-of-use asset		$ 144.3
Lease liability		$ 144
ASU 2016-02
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Right-of-use asset			$ 200.9
Lease liability			$ 251.5

Business Combinations - Narrati

Business Combinations - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	May 24, 2019	Jun. 30, 2019	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Business Acquisition [Line Items]
Transaction, integration, and restructuring			$ 304.9	$ 23.5	$ 351	$ 42
OppenheimerFunds
Business Acquisition [Line Items]
Cash consideration	$ 19.6
Preferred shares dividend rate (percent)					5.90%
Liquidation preference per share (in usd per share)	$ 1,000
Revenues of acquired entity		$ 217.1
Transaction, integration, and restructuring			295.7		$ 330.6
Common and Restricted Stock | OppenheimerFunds
Business Acquisition [Line Items]
Shares of common stock issued (shares)	81,900,000
Other equity securities | OppenheimerFunds
Business Acquisition [Line Items]
Shares of common stock issued (shares)	75,700,000
Perpetual, non-cumulative preferred shares issued (shares)	$ 1,453.6
Lock-up period	2 years
Preferred shares | OppenheimerFunds
Business Acquisition [Line Items]
Perpetual, non-cumulative preferred shares issued (shares)	$ 4,010.5
Non-call period	21 years
Preferred shares dividend rate (percent)	5.90%
Lock-up period	5 years
Restricted stock awards | OppenheimerFunds
Business Acquisition [Line Items]
Shares of common stock issued (shares)	6,200,000
MassMutual | Preferred shares | OppenheimerFunds
Business Acquisition [Line Items]
Approximate stake help in common stock of combined firm (percent)	16.10%
Management contracts | OppenheimerFunds
Business Acquisition [Line Items]
Finite lived intangible assets acquired	$ 221
Estimated useful life	8 years
Management contracts | OppenheimerFunds
Business Acquisition [Line Items]
Indefinite-lived intangible assets acquired	$ 4,955
Trade names | OppenheimerFunds
Business Acquisition [Line Items]
Finite lived intangible assets acquired	$ 29
Estimated useful life	6 years
MassMutual | Other equity securities | OppenheimerFunds
Business Acquisition [Line Items]
Shares of common stock issued (shares)	75,563,041
Share price (in usd per share)	$ 19.195
Others | Other equity securities | OppenheimerFunds
Business Acquisition [Line Items]
Shares of common stock issued (shares)	153,574
Share price (in usd per share)	$ 20.42
Acquisition-related costs | OppenheimerFunds
Business Acquisition [Line Items]
Transaction, integration, and restructuring			$ 49.4		$ 51.9

Business Combinations - Schedul

Business Combinations - Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Millions	May 24, 2019	Jun. 30, 2019	Dec. 31, 2018
ASSETS
Goodwill		$ 8,389.3	$ 7,157.1
OppenheimerFunds
ASSETS
Cash and cash equivalents	$ 360
Accounts receivable	133.5
Investments	178.4
Prepaid assets	28.9
Other assets	184.2
Property, equipment and software, net	115.2
Intangible assets	5,205
Goodwill	1,180.5
Total assets	7,385.7
LIABILITES
Accrued compensation and benefits	262.1
Accounts payable and accrued expenses	344
Deferred tax liabilities, net	1,199.1
Total liabilities	1,805.2
Total identifiable net assets	5,580.5
Summary of consideration
Cash consideration	19.6
Total cash and stock consideration	5,580.5
Common Shares | OppenheimerFunds
Summary of consideration
Stock consideration	1,453.6
Preferred Shares | OppenheimerFunds
Summary of consideration
Stock consideration	4,010.5
Other consideration | OppenheimerFunds
Summary of consideration
Stock consideration	$ 96.8

Business Combinations - Sched_2

Business Combinations - Schedule of Changes in Carrying Amounts of Goodwill (Details) $ in Millions	6 Months Ended
	Jun. 30, 2019USD ($)
Goodwill [Roll Forward]
January 1, 2019	$ 7,157.1
Business combinations	1,171.9
Foreign exchange	60.3
June 30, 2019	$ 8,389.3

Business Combinations - Sched_3

Business Combinations - Schedule of Pro Forma Information (Details) - OppenheimerFunds - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Operating revenues	$ 1,750.9	$ 1,908.6	$ 3,471.7	$ 3,841.6
Net income	$ 89.7	$ 271.6	$ 305.8	$ 575.2

Fair Value Of Assets And Liab_3

Fair Value Of Assets And Liabilities (Fair Value Of Financial Instruments Held By Consolidated Investments) (Details) - USD ($) $ in Millions	Jun. 30, 2019	Dec. 31, 2018	Jun. 30, 2018
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	$ 1,199.4	$ 1,147.7	$ 1,480.5
Foreign time deposits	26.8	28.1
Policyholder payables	(11,472.6)	(11,384.8)
Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	1,199.4	1,147.7
Equity investments	474.7	283.2
Foreign time deposits	26.8	28.1
Assets held for policyholders	11,472.6	11,384.8
Policyholder payables	(11,472.6)	(11,384.8)
Contingent consideration liability	(49.8)	(40.9)
Long-term debt	(2,120.5)	(2,408.8)
Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	1,199.4	1,147.7
Equity investments	474.7	283.2
Foreign time deposits	26.8	28.1
Assets held for policyholders	11,472.6	11,384.8
Policyholder payables	(11,472.6)	(11,384.8)
Contingent consideration liability	(49.8)	(40.9)
Long-term debt	$ (2,270.5)	$ (2,418.2)

Fair Value Of Assets And Liab_4

Fair Value Of Assets And Liabilities (Tri-Level Hierarchy, Carrying Value) (Details) - USD ($) $ in Millions	Jun. 30, 2019	Dec. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held for policyholders	$ 11,472.6	$ 11,384.8
Total	12,602.7	12,035.6
Total	(49.8)	(40.9)
Contingent consideration liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration liability	(49.8)	(40.9)
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	655.4	367.6
Seed money
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity investments	230.3	202.8
Investments related to deferred compensation plans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity investments	240.9	78.6
Other equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity investments	3.5	1.8
Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held for policyholders	11,472.6	11,384.8
Total	12,602.7	12,035.6
Total	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Contingent consideration liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration liability	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	655.4	367.6
Quoted Prices in Active Markets for Identical Assets (Level 1) | Seed money
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity investments	230.3	202.8
Quoted Prices in Active Markets for Identical Assets (Level 1) | Investments related to deferred compensation plans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity investments	240.9	78.6
Quoted Prices in Active Markets for Identical Assets (Level 1) | Other equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity investments	3.5	1.8
Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held for policyholders	0	0
Total	0	0
Total	0	0
Significant Other Observable Inputs (Level 2) | Contingent consideration liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration liability	0	0
Significant Other Observable Inputs (Level 2) | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	0	0
Significant Other Observable Inputs (Level 2) | Seed money
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity investments	0	0
Significant Other Observable Inputs (Level 2) | Investments related to deferred compensation plans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity investments	0	0
Significant Other Observable Inputs (Level 2) | Other equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity investments	0	0
Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held for policyholders	0	0
Total	0	0
Total	(49.8)	(40.9)
Significant Unobservable Inputs (Level 3) | Contingent consideration liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration liability	(49.8)	(40.9)
Significant Unobservable Inputs (Level 3) | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	0	0
Significant Unobservable Inputs (Level 3) | Seed money
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity investments	0	0
Significant Unobservable Inputs (Level 3) | Investments related to deferred compensation plans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity investments	0	0
Significant Unobservable Inputs (Level 3) | Other equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity investments	$ 0	$ 0

Fair Value Of Assets And Liab_5

Fair Value Of Assets And Liabilities (Narrative) (Details) $ in Millions	6 Months Ended
	Jun. 30, 2019USD ($)	May 24, 2019USD ($)	Dec. 31, 2018USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign time deposits	$ 26.8		$ 28.1
Equity method investments	310.5		296.3
Other investments	$ 27.9		5.9
Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assumed growth rate of Assets under Management (percent)	(9.44%)
Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assumed growth rate of Assets under Management (percent)	5.73%
Weighted Average
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assumed growth rate of Assets under Management (percent)	(0.54%)
Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign time deposits	$ 26.8		$ 28.1
Discount rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Inputs used to determine liability (percent)	0.0392
Put Option
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Additional put option contract purchased	$ 3.9
Total Return Swap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative notional amount	164.8
Gain on derivative	3.3
Total Return Swap | Designated as Hedging Instrument
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative notional amount	136
Gain on derivatives	$ 1.7
OppenheimerFunds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration liability acquired		$ 13.6
OppenheimerFunds | Assumed growth rate | Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Inputs used to determine liability (percent)	0.28
OppenheimerFunds | Assumed growth rate | Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Inputs used to determine liability (percent)	0.33
OppenheimerFunds | Discount rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Inputs used to determine liability (percent)	0.107

Fair Value Of Assets And Liab_6

Fair Value Of Assets And Liabilities (Reconciliation Of Balance, Fair Value Measurement, Level 3) (Details) - Significant Unobservable Inputs (Level 3) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance (Asset)	$ 12.2	$ 81.2	$ 11.8	$ 76.2
Net unrealized gains and losses included in other gains and losses, net	2.3	2.6	2.7	8.3
Disposition/settlements (Asset)		(44.8)		(45.5)
Ending balance (Asset)	14.5	52	14.5	52
Other debt securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance (Asset)		6.2		9.9
Net unrealized gains and losses included in other gains and losses, net		0		0
Disposition/settlements (Asset)		(6.2)		(9.9)
Ending balance (Asset)		0		0
Contingent consideration liability
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance (Liability)	(38.4)	(53.6)	(40.9)	(57.4)
Contingent consideration liability acquired in business combination	(15.5)		(15.5)
Net unrealized gains and losses included in other gains and losses, net	0.5	(0.2)	(1)	0.2
Disposition / settlements (Liability)	3.6	3.7	7.6	7.1
Ending balance (Liability)	$ (49.8)	$ (50.1)	$ (49.8)	$ (50.1)

Investments (Narrative) (Detail

Investments (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Short-term Investments
Debt Securities, Available-for-sale [Line Items]
Unrealized gains and (losses)	$ 12.7	$ (9.9)	$ 39.4	$ (9.7)

Investments (Details Of Company

Investments (Details Of Company Investments) (Details) - USD ($) $ in Millions	Jun. 30, 2019	Dec. 31, 2018
Investment Holdings [Line Items]
Equity method investments	$ 310.5	$ 296.3
Foreign time deposits	26.8	28.1
Other	27.9	5.9
Investments	839.9	613.5
Seed money
Investment Holdings [Line Items]
Equity investments	230.3	202.8
Investments related to deferred compensation plans
Investment Holdings [Line Items]
Equity investments	240.9	78.6
Other equity securities
Investment Holdings [Line Items]
Equity investments	$ 3.5	$ 1.8

Investments (Realized Gains Los

Investments (Realized Gains Losses Available-For-Sale Securities) (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2018
Debt Securities, Available-for-sale [Line Items]
Proceeds from Sales	$ 16	$ 18.6
Gross Realized Gains	0.8	0.8
Gross Realized Losses	(3.5)	(3.6)
Collateralized Loan Obligations (CLOs)
Debt Securities, Available-for-sale [Line Items]
Proceeds from Sales	9.7	12.3
Gross Realized Gains	0.8	0.8
Gross Realized Losses	0	0
Other debt securities
Debt Securities, Available-for-sale [Line Items]
Proceeds from Sales	6.3	6.3
Gross Realized Gains	0	0
Gross Realized Losses	$ (3.5)	$ (3.6)

Long-Term Debt (Schedule Of Lon

Long-Term Debt (Schedule Of Long-Term Debt Instruments) (Details) - USD ($)	6 Months Ended
	Jun. 30, 2019	Dec. 31, 2018
Unsecured Senior Notes | $600 million 3.125% - due November 30, 2022
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	3.125%
Debt instrument, face amount	$ 600,000,000
Debt Instrument, maturity date	Nov. 30, 2022
Unsecured Senior Notes | $600 million 4.000% - due January 30, 2024
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	4.00%
Debt instrument, face amount	$ 600,000,000
Debt Instrument, maturity date	Jan. 30, 2024
Unsecured Senior Notes | $500 million 3.750% - due January 15, 2026
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	3.75%
Debt instrument, face amount	$ 500,000,000
Debt Instrument, maturity date	Jan. 15, 2026
Unsecured Senior Notes | $400 million 5.375% - due November 30, 2043
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	5.375%
Debt instrument, face amount	$ 400,000,000
Debt Instrument, maturity date	Nov. 30, 2043
$1.5 billion floating rate credit facility expiring August 11, 2022
Debt Instrument [Line Items]
Debt instrument, face amount	$ 1,500,000,000
Credit facility expiration date	Aug. 11, 2022
Carrying Value
Debt Instrument [Line Items]
Long-term debt	$ 2,120,500,000	$ 2,408,800,000
Carrying Value | Unsecured Senior Notes | $600 million 3.125% - due November 30, 2022
Debt Instrument [Line Items]
Long-term debt	597,800,000	597,500,000
Carrying Value | Unsecured Senior Notes | $600 million 4.000% - due January 30, 2024
Debt Instrument [Line Items]
Long-term debt	595,400,000	594,900,000
Carrying Value | Unsecured Senior Notes | $500 million 3.750% - due January 15, 2026
Debt Instrument [Line Items]
Long-term debt	495,900,000	495,600,000
Carrying Value | Unsecured Senior Notes | $400 million 5.375% - due November 30, 2043
Debt Instrument [Line Items]
Long-term debt	390,000,000	390,000,000
Carrying Value | $1.5 billion floating rate credit facility expiring August 11, 2022
Debt Instrument [Line Items]
Line of credit facility, amount outstanding	41,400,000	330,800,000
Fair Value
Debt Instrument [Line Items]
Long-term debt	2,270,500,000	2,418,200,000
Fair Value | Unsecured Senior Notes | $600 million 3.125% - due November 30, 2022
Debt Instrument [Line Items]
Long-term debt	614,000,000	585,200,000
Fair Value | Unsecured Senior Notes | $600 million 4.000% - due January 30, 2024
Debt Instrument [Line Items]
Long-term debt	637,400,000	594,500,000
Fair Value | Unsecured Senior Notes | $500 million 3.750% - due January 15, 2026
Debt Instrument [Line Items]
Long-term debt	523,800,000	487,600,000
Fair Value | Unsecured Senior Notes | $400 million 5.375% - due November 30, 2043
Debt Instrument [Line Items]
Long-term debt	453,900,000	420,100,000
Fair Value | $1.5 billion floating rate credit facility expiring August 11, 2022
Debt Instrument [Line Items]
Line of credit facility, amount outstanding	$ 41,400,000	$ 330,800,000

Long-Term Debt (Narrative) (Det

Long-Term Debt (Narrative) (Details) - Letter of Credit $ in Millions	6 Months Ended
	Jun. 30, 2019USD ($)
Line of Credit Facility [Line Items]
Capacity on letters of credit	$ 11.3
Letters of credit, renewable term	1 year

Share Capital - Narrative (Deta

Share Capital - Narrative (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	May 13, 2019	Jun. 30, 2019
Class of Stock [Line Items]
Preferred stock par value (in usd per share)		$ 0.2
Liquidation preference per share (in usd per share)		$ 1,000
Preferred shares lock-up period		5 years
OppenheimerFunds
Class of Stock [Line Items]
Preferred stock par value (in usd per share)		$ 0.20
Liquidation preference per share (in usd per share)		$ 1,000
Preferred shares dividend rate (percent)		5.90%
Common Shares | Forward contract
Class of Stock [Line Items]
Number of shares to be purchased under forward contract (shares)	9.8
Forward contract strike price (in usd per share)	$ 20.51
Value of treasury shares recorded	$ 198.7
Collateral related to the forward contract		$ 8.6
Derivative notional amount		$ 200

Share Capital (Movements In Sha

Share Capital (Movements In Shares Issued And Outstanding) (Details) - shares shares in Millions	Jun. 30, 2019	Dec. 31, 2018
Equity [Abstract]
Preferred shares issued (shares)	4	0
Preferred shares outstanding (shares)	4	0
Common shares issued (shares)	566.1	490.4
Less: Treasury shares for which dividend and voting rights do not apply (shares)	(96.3)	(93.3)
Common shares outstanding (shares)	469.8	397.1

Other Comprehensive Income_(L_3

Other Comprehensive Income/(Loss) (Accumulated other comprehensive income) (Details) £ in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019USD ($)	Jun. 30, 2018USD ($)	Jun. 30, 2019USD ($)	Jun. 30, 2018USD ($)	Jun. 30, 2019GBP (£)	Dec. 31, 2018USD ($)	Dec. 31, 2018GBP (£)	Jan. 01, 2018USD ($)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Currency translation differences on investments in foreign subsidiaries	$ 1.5	$ (233.6)	$ 62.4	$ (169)
Other comprehensive income, net	0.7	1.3	1.2	(0.3)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			(735)
January 1, 2018, as adjusted								$ 8,955.6
Other comprehensive income/(loss)	2.2	(232.3)	63.6	(169.3)
Ending balance	(671.4)		(671.4)
Foreign currency transaction and translation gain (loss)	4.2	10.9	0.1	4.3
Foreign currency translation
Accumulated Other Comprehensive Income (Loss) [Line Items]
Currency translation differences on investments in foreign subsidiaries	1.5	(233.6)	62.4	(169)
Other comprehensive income, net	0	0	0	0
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(556.7)	(225.9)	(617.6)	(290.5)
Other comprehensive income/(loss)	1.5	(233.6)	62.4	(169)
Ending balance	(555.2)	(459.5)	(555.2)	(459.5)
Employee benefit plans
Accumulated Other Comprehensive Income (Loss) [Line Items]
Currency translation differences on investments in foreign subsidiaries	0	0	0	0
Other comprehensive income, net	0.6	1.9	0.8	2.3
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(117.5)	(109.3)	(117.7)	(109.7)
Other comprehensive income/(loss)	0.6	1.9	0.8	2.3
Ending balance	(116.9)	(107.4)	(116.9)	(107.4)
Available-for-sale investments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Currency translation differences on investments in foreign subsidiaries	0	0	0	0
Other comprehensive income, net	0	(0.6)	0.3	(0.3)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	0.6	1.8	0.3	4.7
Other comprehensive income/(loss)	0	(0.6)	0.3	(0.3)
Ending balance	0.6	1.2	0.6	1.2
Accumulated Other Comprehensive Income/(Loss)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(673.6)	(331.4)	(735)	(391.2)
January 1, 2018, as adjusted								(394.4)
Other comprehensive income/(loss)	2.2	(232.3)
Ending balance	(671.4)	(563.7)	(671.4)	(563.7)
Designated as Hedging Instrument
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Intercompany debt	165.5		165.5		£ 130	$ 165.6	£ 130
Equity method investments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Currency translation differences on investments in foreign subsidiaries	0	0	0	0
Other comprehensive income, net	0.1	0	0.1	(2.3)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	0	2	0	4.3
Other comprehensive income/(loss)	0.1	0	0.1	(2.3)
Ending balance	$ 0.1	$ 2	$ 0.1	2
Adjustment for adoption of ASU 2016-01
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Adjustment for adoption of ASU 2016-01				(3.2)
January 1, 2018, as adjusted								(394.4)
Adjustment for adoption of ASU 2016-01 | Foreign currency translation
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Adjustment for adoption of ASU 2016-01				0
January 1, 2018, as adjusted								(290.5)
Adjustment for adoption of ASU 2016-01 | Employee benefit plans
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Adjustment for adoption of ASU 2016-01				0
January 1, 2018, as adjusted								(109.7)
Adjustment for adoption of ASU 2016-01 | Available-for-sale investments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Adjustment for adoption of ASU 2016-01				(3.2)
January 1, 2018, as adjusted								1.5
Adjustment for adoption of ASU 2016-01 | Equity method investments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Adjustment for adoption of ASU 2016-01				$ 0
January 1, 2018, as adjusted								$ 4.3

Revenue (Details)

Revenue (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018
Revenue, Major Customer [Line Items]
Total operating revenues	$ 1,439,400,000	$ 1,360,600,000	$ 2,654,000,000	$ 2,716,400,000
Deferred carried interest liabilities	55,900,000	60,400,000	55,900,000	60,400,000	$ 61,300,000
Performance revenue recognized			5,900,000	0
Bermuda
Revenue, Major Customer [Line Items]
Total operating revenues		0	0	0
Americas
Revenue, Major Customer [Line Items]
Total operating revenues	992,300,000	830,200,000	1,752,300,000	1,648,200,000
EMEA (Europe, Middle East, and Africa)
Revenue, Major Customer [Line Items]
Total operating revenues	378,600,000	456,400,000	758,900,000	926,300,000
Asia-Pacific
Revenue, Major Customer [Line Items]
Total operating revenues	$ 68,500,000	$ 74,000,000	$ 142,800,000	$ 141,900,000

Common Share-Based Compensati_3

Common Share-Based Compensation (Narrative) (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	May 24, 2019	Jun. 30, 2019	Jun. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common share-based compensation expense		$ 109.4	$ 81.8
Fair value of vested shares		$ 133.3	$ 153.1
Weighted average fair value of shares granted (usd per share)		$ 19.77	$ 32.52
Unrecognized compensation cost related to non-vested shares		$ 384.4
Weighted average non-vested shares compensation cost expected to recognize		2 years 8 months 19 days
Restricted stock awards | OppenheimerFunds
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock issued (shares)	6.2
Cliff vesting period	4 years

Common Share-Based Compensati_4

Common Share-Based Compensation (Movements On Share Awards) (Details) - $ / shares shares in Millions	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Unvested at beginning of year Weighted Average Grant Date Fair Value (usd per share)	$ 31.46
Granted during period Weighted Average Grant Date Fair Value (usd per share)	19.77	$ 32.52
Forfeited during period Weighted Average Grant Date Fair Value (usd per share)	26.63
Vested and distributed during the period Weighted Average Grant Date Fair Value (usd per share)	28.78
Unvested at the end of the year Weighted Average Grant Date Fair Value (usd per share)	$ 24.02
Time- Vested
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Unvested at the beginning of year (shares)	12.5	12
Granted during the year (shares)	15	5.2
Forfeited during the period (shares)	(0.4)	(0.1)
Vested and distributed during the year (shares)	(6.6)	(4.6)
Unvested at the end of the year (shares)	20.5	12.5
Performance- Vested
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Unvested at the beginning of year (shares)	0.9	0.9
Granted during the year (shares)	0.6	0.4
Forfeited during the period (shares)	0	0
Vested and distributed during the year (shares)	(0.1)	(0.4)
Unvested at the end of the year (shares)	1.4	0.9

Operating Leases (Details)

Operating Leases (Details) $ in Millions	6 Months Ended
	Jun. 30, 2019USD ($)lease_renewal_option
Lessee, Lease, Description [Line Items]
Weighted-average remaining lease term	6 years 10 months 17 days
Number of lease renewal options (at least) | lease_renewal_option	1
Right-of-use asset	$ 334.2
Lease liability	$ 379.1
Weighted average discount rate for the operating leases (percent)	3.53%
Minimum
Lessee, Lease, Description [Line Items]
Renewal lease terms	2 years
Options to terminate leases within period	1 year
Maximum
Lessee, Lease, Description [Line Items]
Renewal lease terms	10 years
Options to terminate leases within period	2 years

Operating Leases - Components o

Operating Leases - Components of Lease Expense (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2019
Leases [Abstract]
Operating lease cost	$ 16.1	$ 29.8
Variable lease cost	6.9	12.8
Less: sublease income	(0.1)	(0.3)
Total lease expense	22.9	42.3
Operating cash flows from operating leases included in the measurement of lease liabilities	18.5	33.5
Right-of-use assets obtained in exchange for new operating lease liabilities	$ 144.3	$ 148.5

Operating Leases - Maturities o

Operating Leases - Maturities of Leases (Details) - USD ($) $ in Millions	Jun. 30, 2019	Dec. 31, 2018
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
2019 (excluding the six months ended June 30, 2019)	$ 38.6
2020	71.2
2021	66.6
2022	59.2
2023	52.7
Thereafter	140.2
Total lease payments	428.5
Less: interest	(49.4)
Present value of lease liabilities	$ 379.1
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
2019		$ 61.6
2020		56.3
2021		49.3
2022		42.8
2023		36.7
Thereafter		53.5
Gross lease commitments		300.2
Less: future minimum payments expected to be received under non-cancelable subleases		(2.5)
Net lease commitments		$ 297.7

Taxation - Reconciliation of be

Taxation - Reconciliation of beginning and ending amounts of unrecognized tax benefits (Details) $ in Millions	6 Months Ended
	Jun. 30, 2019USD ($)
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance at December 31, 2018	$ 20
Additions for tax positions related to the current year	0.7
Additions for tax positions related to prior years	0.2
Additions for tax positions related to acquisitions	54.1
Other reductions for tax positions related to prior years	(5.3)
Balance at June 30, 2019	$ 69.7

Taxation (Narrative) (Details)

Taxation (Narrative) (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2019	Dec. 31, 2018
Income Tax Contingency [Line Items]
Unrecognized tax benefits	$ 69.7	$ 20
Additions for tax positions related to acquisitions	54.1
Other reductions for tax positions related to prior years	5.3
Unrecognized tax benefits that would impact effective tax rate	53.8
Accrued interest and penalties	12.7
Tax indemnification asset	22.1
Minimum
Income Tax Contingency [Line Items]
Possible change in unrecognized tax benefits within twelve months	5
Maximum
Income Tax Contingency [Line Items]
Possible change in unrecognized tax benefits within twelve months	15
OppenheimerFunds
Income Tax Contingency [Line Items]
Accrued interest and penalties	$ 9.5

Earnings Per Common Share (Calc

Earnings Per Common Share (Calculation Of Earnings Per Share) (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Earnings Per Share [Abstract]
Net income attributable to Invesco Ltd.	$ 40.1	$ 245.1	$ 217.8	$ 499
Weighted average shares outstanding - basic (in shares)	431.6	413.9	416.7	412.6
Dilutive effect of non-participating common share-based awards (in shares)	2.2	0.2	1.5	0.3
Weighted average shares outstanding - diluted (in shares)	433.8	414.1	418.2	412.9
Earnings per common share:
Basic earnings per common share (usd per share)	$ 0.09	$ 0.59	$ 0.52	$ 1.21
Diluted earnings per common share (usd per share)	0.09	0.59	0.52	1.21
Dividends declared per common share (usd per share)	$ 0.31	$ 0.30	$ 0.61	$ 0.59

Earnings Per Common Share (Narr

Earnings Per Common Share (Narrative) (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Contingently issuable share excluded	0	0	0	0
Performance- Vested
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	800,000	700,000	800,000	700,000
Time- Vested
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	0		0

Commitments And Contingencies (

Commitments And Contingencies (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Jun. 30, 2019	Dec. 31, 2018
Commitments and Contingencies Disclosure [Abstract]
Undrawn capital commitments	$ 335	$ 391.6

Consolidated Investment Produ_3

Consolidated Investment Products (Balances Related To CIP) (Details) - USD ($) $ in Millions	Jun. 30, 2019	Dec. 31, 2018	Jun. 30, 2018
Consolidated Investment Products [Abstract]
Cash and cash equivalents of CIP	$ 235.9	$ 657.7	$ 353.4
Accounts receivable and other assets of CIP	186.5	110.8
Investments of CIP	6,659.9	6,213.5
Less: Debt of CIP	(5,149.6)	(5,226)
Less: Other liabilities of CIP	(565.7)	(387.6)
Less: Retained earnings	7.3	7.9
Less: Accumulated other comprehensive income, net of tax	(7.2)	(7.8)
Less: Redeemable Noncontrolling Interest, Consolidated Investment Products	(396.4)	(396.2)
Less: Equity attributable to nonredeemable noncontrolling interests	(364.1)	(356.5)
Invesco’s net interests in CIP	$ 606.6	$ 615.8

Consolidated Investment Produ_4

Consolidated Investment Products (CIP) (Narrative) (Details)	6 Months Ended
	Jun. 30, 2019USD ($)entityvariable_interest_entity	Jun. 30, 2018USD ($)variable_interest_entity	Mar. 31, 2019USD ($)	Dec. 31, 2018USD ($)	Mar. 31, 2018USD ($)	Dec. 31, 2017USD ($)
Variable Interest Entity [Line Items]
Carrying amounts of nonconsolidated VIEs' assets	$ 173,200,000			$ 181,800,000
Maximum loss exposure of VIEs	$ 190,700,000			181,800,000
Number of consolidated VIEs | variable_interest_entity	2	2
Number of entities no longer consolidated | variable_interest_entity	5	2
Number of Nonconsolidated VOEs | entity	8
Gain (loss) on deconsolidation	$ 0	$ 0
Net unrealized gains	$ 2,700,000	$ 21,100,000
Pay interest at Libor or Euribor plus	10.00%
Collateral assets in default (percent)	0.18%	1.00%
Notes issued by collateralized loan obligations terms of arrangements interest rate margin spread low	0.55%
Notes issued by collateralized loan obligations terms of arrangements interest rate margin spread high	7.45%
Investments of CIP	$ 6,659,900,000			6,213,500,000
Collateralized Loan Obligations (CLOs)
Variable Interest Entity [Line Items]
Weighted average maturity (years)	10 years 9 months 18 days
Bank loans
Variable Interest Entity [Line Items]
CLO Collateral Assets	$ 5,554,000,000			5,117,000,000
Senior Secured Bank Loans And Bonds | Collateralized Loan Obligations (CLOs)
Variable Interest Entity [Line Items]
Fair value, option, aggregate differences, long-term debt instruments	122,400,000			134,300,000
Eliminations | Bank loans | Collateralized Loan Obligations (CLOs)
Variable Interest Entity [Line Items]
CLO Collateral Assets	5,516,700,000
Significant Unobservable Inputs (Level 3)
Variable Interest Entity [Line Items]
Real Estate Investments, Net	14,500,000	$ 52,000,000	$ 12,200,000	11,800,000	$ 81,200,000	$ 76,200,000
Investments of CIP	14,500,000			11,800,000
Significant Unobservable Inputs (Level 3) | Bank loans
Variable Interest Entity [Line Items]
CLO Collateral Assets	$ 0			$ 0

Consolidated Investment Produ_5

Consolidated Investment Products (Condensed Consolidating Statement Of Income Line Items Reflecting Impact Of Consolidation Of Investment Products Into The Condensed Consolidated Statements Of Income) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Statement [Line Items]
Total operating expenses	$ 1,421.1	$ 1,029.3	$ 2,435.5	$ 2,064
Operating income	18.3	331.3	218.5	652.4
Equity in earnings of unconsolidated affiliates	12.1	7.3	27.1	17
Interest and dividend income	3.9	2.8	8.6	7
Other gains and losses, net	24.1	1.4	55.2	(4)
Other gains/(losses) of CIP, net	51.1	0.9	90	28.1
Income before income taxes	76.5	314.2	333.3	647.8
Income tax provision	(14.5)	(72.3)	(80.7)	(140.7)
Net income	62	241.9	252.6	507.1
Net (income)/loss attributable to noncontrolling interests in consolidated entities	(21.9)	3.2	(34.8)	(8.1)
Net income attributable to Invesco Ltd.	40.1	245.1	217.8	499
Impact of CIP
Statement [Line Items]
Total operating revenues	(7.2)	(7.1)	(15.9)	(14.1)
Total operating expenses	5.4	6.2	8.2	9.4
Operating income	(12.6)	(13.3)	(24.1)	(23.5)
Equity in earnings of unconsolidated affiliates	(5.7)	(2.1)	0.9	(6.3)
Interest and dividend income	(1)	0	(2.4)	0
Other gains and losses, net	(8.3)	9.1	(29)	8.2
Interest and dividend income of CIP	86.7	67.2	171.4	125
Interest expense of CIP	(54.8)	(46.4)	(112.8)	(85.8)
Other gains/(losses) of CIP, net	19.2	(19.9)	31.4	(11.1)
Income before income taxes	23.5	(5.4)	35.4	6.5
Income tax provision	0	0	0	0
Net income	23.5	(5.4)	35.4	6.5
Net (income)/loss attributable to noncontrolling interests in consolidated entities	(21.9)	3.2	(34.8)	(8.1)
Net income attributable to Invesco Ltd.	$ 1.6	$ (2.2)	$ 0.6	$ (1.6)

Consolidated Investment Produ_6

Consolidated Investment Products (VIE Balance Sheets Consolidated In Period) (Details) - USD ($) $ in Millions	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017
Variable Interest Entity [Line Items]
Cash and cash equivalents of CIP	$ 235.9		$ 657.7	$ 353.4
Accounts receivable and other assets of CIP	186.5		110.8
Investments of CIP	6,659.9		6,213.5
Total assets	38,501.4		30,978.4
Debt of CIP	5,149.6		5,226
Other liabilities of CIP	565.7		387.6
Total liabilities	23,805.3		21,646
Total equity	14,299.7	$ 9,009.4	8,936.2	9,136.2	$ 9,190	$ 8,955.6
Total liabilities, temporary and permanent equity	38,501.4		$ 30,978.4
CLOs - VIEs
Variable Interest Entity [Line Items]
Cash and cash equivalents of CIP	7.7			39.3
Accounts receivable and other assets of CIP	22.1			8.3
Investments of CIP	613.4			339.9
Total assets	643.2			387.5
Debt of CIP	526.2			375.3
Other liabilities of CIP	22.2			3.2
Total liabilities	548.4			378.5
Total equity	94.8			9
Total liabilities, temporary and permanent equity	643.2			387.5
VOEs
Variable Interest Entity [Line Items]
Cash and cash equivalents of CIP	(0.1)
Accounts receivable and other assets of CIP	0.2
Investments of CIP	26.7
Total assets	26.8
Debt of CIP	0
Other liabilities of CIP	0
Total liabilities	0
Total equity	26.8
Total liabilities, temporary and permanent equity	26.8
Consolidated Entities | CLOs - VIEs
Variable Interest Entity [Line Items]
Cash and cash equivalents of CIP	4			3.4
Accounts receivable and other assets of CIP	3			3.4
Investments of CIP	225.4			584.9
Total assets	232.4			591.7
Debt of CIP	177.9			555.2
Other liabilities of CIP	54.5			36.5
Total liabilities	232.4			591.7
Total equity	0			0
Total liabilities, temporary and permanent equity	$ 232.4			$ 591.7

Consolidated Investment Produ_7

Consolidated Investment Products (Fair Value Hierarchy Levels Of Investments Held And Notes Issued By Consolidated Investment Products) (Details) - USD ($) $ in Millions	Jun. 30, 2019	Dec. 31, 2018
Statement [Line Items]
Real estate investments	$ 14.5	$ 11.8
Total assets at fair value	6,659.9	6,213.5
Quoted Prices in Active Markets for Identical Assets (Level 1)
Statement [Line Items]
Real estate investments	0	0
Total assets at fair value	210.6	226.9
Significant Other Observable Inputs (Level 2)
Statement [Line Items]
Real estate investments	0	0
Total assets at fair value	6,251.2	5,786.1
Significant Unobservable Inputs (Level 3)
Statement [Line Items]
Real estate investments	14.5	11.8
Total assets at fair value	14.5	11.8
Investments Measured at NAV as a practical expedient
Statement [Line Items]
Real estate investments	0	0
Total assets at fair value	183.5	188.7
Bank loans
Statement [Line Items]
Bank loan, bonds and equity securities	5,554	5,117
Bank loans | Quoted Prices in Active Markets for Identical Assets (Level 1)
Statement [Line Items]
Bank loan, bonds and equity securities	0	0
Bank loans | Significant Other Observable Inputs (Level 2)
Statement [Line Items]
Bank loan, bonds and equity securities	5,554	5,117
Bank loans | Significant Unobservable Inputs (Level 3)
Statement [Line Items]
Bank loan, bonds and equity securities	0	0
Bank loans | Investments Measured at NAV as a practical expedient
Statement [Line Items]
Bank loan, bonds and equity securities	0	0
Bonds
Statement [Line Items]
Bank loan, bonds and equity securities	642.2	636
Bonds | Quoted Prices in Active Markets for Identical Assets (Level 1)
Statement [Line Items]
Bank loan, bonds and equity securities	0.4	0
Bonds | Significant Other Observable Inputs (Level 2)
Statement [Line Items]
Bank loan, bonds and equity securities	641.7	636
Bonds | Significant Unobservable Inputs (Level 3)
Statement [Line Items]
Bank loan, bonds and equity securities	0	0
Bonds | Investments Measured at NAV as a practical expedient
Statement [Line Items]
Bank loan, bonds and equity securities	0	0
Equity securities, Equity and fixed income mutual funds
Statement [Line Items]
Bank loan, bonds and equity securities	246.8	241.2
Equity and fixed income mutual funds, and investments in other private equity funds	18.9	18.8
Equity securities, Equity and fixed income mutual funds | Quoted Prices in Active Markets for Identical Assets (Level 1)
Statement [Line Items]
Bank loan, bonds and equity securities	191.3	208.1
Equity and fixed income mutual funds, and investments in other private equity funds	18.9	18.8
Equity securities, Equity and fixed income mutual funds | Significant Other Observable Inputs (Level 2)
Statement [Line Items]
Bank loan, bonds and equity securities	55.5	33.1
Equity and fixed income mutual funds, and investments in other private equity funds	0	0
Equity securities, Equity and fixed income mutual funds | Significant Unobservable Inputs (Level 3)
Statement [Line Items]
Bank loan, bonds and equity securities	0	0
Equity and fixed income mutual funds, and investments in other private equity funds	0	0
Equity securities, Equity and fixed income mutual funds | Investments Measured at NAV as a practical expedient
Statement [Line Items]
Bank loan, bonds and equity securities	0	0
Equity and fixed income mutual funds, and investments in other private equity funds	0	0
Investments in other private equity funds
Statement [Line Items]
Equity and fixed income mutual funds, and investments in other private equity funds	183.5	188.7
Investments in other private equity funds | Quoted Prices in Active Markets for Identical Assets (Level 1)
Statement [Line Items]
Equity and fixed income mutual funds, and investments in other private equity funds	0	0
Investments in other private equity funds | Significant Other Observable Inputs (Level 2)
Statement [Line Items]
Equity and fixed income mutual funds, and investments in other private equity funds	0	0
Investments in other private equity funds | Significant Unobservable Inputs (Level 3)
Statement [Line Items]
Equity and fixed income mutual funds, and investments in other private equity funds	0	0
Investments in other private equity funds | Investments Measured at NAV as a practical expedient
Statement [Line Items]
Equity and fixed income mutual funds, and investments in other private equity funds	$ 183.5	$ 188.7

Consolidated Investment Produ_8

Consolidated Investment Products (Beginning And Ending Fair Value Measurements For Level 3 Assets And Liabilities) (Details) - Significant Unobservable Inputs (Level 3) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance (Asset)	$ 12.2	$ 81.2	$ 11.8	$ 76.2
Purchases (Asset)		13		13
Sales (Asset)		(44.8)		(45.5)
Gains and losses included in the Condensed Consolidated Statements of Income	2.3	2.6	2.7	8.3
Ending balance (Asset)	$ 14.5	$ 52	$ 14.5	$ 52

Consolidated Investment Produ_9

Consolidated Investment Products (Investments Measured at NAV as a practical expedient) (Details) - Investments in other private equity funds - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Jun. 30, 2019	Dec. 31, 2018
Schedule of Investments [Line Items]
Fair Value	$ 183.5	$ 188.7
Total Unfunded Commitments	$ 100.9	$ 101.9
Weighted Average Remaining Term	6 years 7 months 6 days	6 years 1 month 6 days

Related Parties Narrative (Deta

Related Parties Narrative (Details) - Preferred Shares - OppenheimerFunds $ in Millions	May 24, 2019USD ($)
Related Party Transactions [Line Items]
Stock consideration	$ 4,010.5
MassMutual
Related Party Transactions [Line Items]
Approximate stake help in common stock of combined firm (percent)	16.10%

Related Parties (Details)

Related Parties (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018
Related Party Transactions [Line Items]
Total operating revenues	$ 1,439.4	$ 1,360.6	$ 2,654	$ 2,716.4
Cash and cash equivalents	1,199.4	1,480.5	1,199.4	1,480.5	$ 1,147.7
Unsettled fund receivables	309.4		309.4		191.3
Accounts receivable	664.6		664.6		604
Investments	839.9		839.9		613.5
Other assets	459.6		459.6		126.1
Total assets	38,501.4		38,501.4		30,978.4
Accrued compensation and benefits	726.7		726.7		646.5
Accounts payable and accrued expenses	1,950		1,950		1,087.2
Unsettled fund payables	281.4		281.4		178.7
Total liabilities	23,805.3		23,805.3		21,646
Affiliated Entity
Related Party Transactions [Line Items]
Total operating revenues	1,301.1	1,213.7	2,384.6	2,434
Cash and cash equivalents	655.4		655.4		367.6
Unsettled fund receivables	251.8		251.8		105
Accounts receivable	300.3		300.3		391.4
Investments	595		595		655.7
Assets held for policyholders	11,472.3		11,472.3		11,384.5
Other assets	45.4		45.4		3.2
Total assets	13,320.2		13,320.2		12,907.4
Accrued compensation and benefits	62.4		62.4		83.2
Accounts payable and accrued expenses	100.1		100.1		64.8
Unsettled fund payables	249.1		249.1		100.3
Total liabilities	411.6		411.6		$ 248.3
Investment management fees
Related Party Transactions [Line Items]
Total operating revenues	1,071.3	1,050.5	1,995	2,094.2
Investment management fees | Affiliated Entity
Related Party Transactions [Line Items]
Total operating revenues	955.5	925.5	1,771.8	1,841.6
Service and distribution fees
Related Party Transactions [Line Items]
Total operating revenues	294.1	242.9	513.4	489
Service and distribution fees | Affiliated Entity
Related Party Transactions [Line Items]
Total operating revenues	278.6	239.7	488.5	485
Performance fees
Related Party Transactions [Line Items]
Total operating revenues	15.7	11.6	37.5	20.7
Performance fees | Affiliated Entity
Related Party Transactions [Line Items]
Total operating revenues	12.9	2.6	23.4	6.7
Other
Related Party Transactions [Line Items]
Total operating revenues	58.3	55.6	108.1	112.5
Other | Affiliated Entity
Related Party Transactions [Line Items]
Total operating revenues	$ 54.1	$ 45.9	$ 100.9	$ 100.7

Subsequent Events (Details)

Subsequent Events (Details) - $ / shares	Jul. 25, 2019	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Subsequent Event [Line Items]
Common stock dividends declared per share (usd per share)		$ 0.31	$ 0.30	$ 0.61	$ 0.59
Subsequent Event
Subsequent Event [Line Items]
Common stock dividends declared per share (usd per share)	$ 0.31
Preferred stock dividend declared (in usd per share)	$ 16.06

Uncategorized Items - ivz10q2q2

Label	Element	Value
Additional Paid-in Capital [Member]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1	$ 6,282,000,000
Parent [Member]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1	8,696,100,000
Common Stock [Member]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1	98,100,000
Treasury Stock [Member]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1	(2,781,900,000)
Noncontrolling Interest [Member]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1	259,500,000
Retained Earnings [Member]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1	5,492,300,000
Redeemable noncontrolling interest [Member]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1	243,200,000
Accounting Standards Update 2016-01 [Member] | AOCI Attributable to Parent [Member]
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	(3,200,000)
Accounting Standards Update 2016-01 [Member] | Retained Earnings [Member]
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	$ 3,200,000